| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 ABCA1 ABCA2 MYH10 HYOU1 MYO1A DYNC2H1 ANXA1 SMC4 PSMC3 MCM3 MSH4 SRCAP XRCC5 HELQ KIF7 MDN1 ATP11B ABCE1 HELZ2 DDX23 DYNC1H1 KIFC1 ATP5F1B HSP90AB3P | 4.45e-12 | 614 | 149 | 25 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA1 ABCA2 DYNC2H1 SMC4 PSMC3 MCM3 SRCAP XRCC5 HELQ KIF7 GTPBP2 MDN1 ATP11B ABCE1 HELZ2 DNM3 DDX23 DNM1 MMUT DYNC1H1 MX1 KIFC1 DNM2 ATP5F1B HSP90AB3P | 6.19e-10 | 775 | 149 | 25 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 ABCA2 DYNC2H1 SMC4 PSMC3 MCM3 SRCAP XRCC5 HELQ KIF7 MDN1 ATP11B ABCE1 HELZ2 DDX23 DYNC1H1 KIFC1 ATP5F1B HSP90AB3P | 8.14e-10 | 441 | 149 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA1 ABCA2 DYNC2H1 SMC4 PSMC3 MCM3 SRCAP XRCC5 HELQ KIF7 GTPBP2 MDN1 ATP11B ABCE1 HELZ2 DNM3 DDX23 DNM1 MMUT DYNC1H1 MX1 KIFC1 DNM2 ATP5F1B HSP90AB3P | 3.12e-09 | 839 | 149 | 25 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA1 ABCA2 DYNC2H1 SMC4 PSMC3 MCM3 SRCAP XRCC5 HELQ KIF7 GTPBP2 MDN1 ATP11B ABCE1 HELZ2 DNM3 DDX23 DNM1 MMUT DYNC1H1 MX1 KIFC1 DNM2 ATP5F1B HSP90AB3P | 3.20e-09 | 840 | 149 | 25 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA1 ABCA2 DYNC2H1 SMC4 PSMC3 MCM3 SRCAP XRCC5 HELQ KIF7 GTPBP2 MDN1 ATP11B ABCE1 HELZ2 DNM3 DDX23 DNM1 MMUT DYNC1H1 MX1 KIFC1 DNM2 ATP5F1B HSP90AB3P | 3.20e-09 | 840 | 149 | 25 | GO:0016818 |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 5.14e-07 | 22 | 149 | 5 | GO:0050998 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.95e-05 | 118 | 149 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor | 5.53e-05 | 2 | 149 | 2 | GO:0046857 | |
| GeneOntologyMolecularFunction | GMP reductase activity | 5.53e-05 | 2 | 149 | 2 | GO:0003920 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 6.43e-05 | 11 | 149 | 3 | GO:0004143 | |
| GeneOntologyMolecularFunction | helicase activity | 1.86e-04 | 158 | 149 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | floppase activity | 2.12e-04 | 16 | 149 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 2.43e-04 | 41 | 149 | 4 | GO:0001727 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 3.29e-04 | 4 | 149 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.84e-04 | 127 | 149 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase binding | 7.35e-04 | 24 | 149 | 3 | GO:0120283 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.12e-03 | 61 | 149 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | D2 dopamine receptor binding | 1.13e-03 | 7 | 149 | 2 | GO:0031749 | |
| GeneOntologyMolecularFunction | lipid binding | ABCA1 ANXA1 ANXA6 SHBG DGKB DGKG SERPINA6 CPNE5 INPP4B ITPR2 VILL SNX32 SPHK1 ZFYVE26 DNM1 EXOC7 DNM2 | 1.14e-03 | 988 | 149 | 17 | GO:0008289 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.16e-03 | 28 | 149 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.19e-03 | 62 | 149 | 4 | GO:0003678 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 1.50e-03 | 8 | 149 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.86e-03 | 70 | 149 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.92e-03 | 9 | 149 | 2 | GO:0090556 | |
| GeneOntologyCellularComponent | secretory granule | PSMB7 PSMC3 XRCC5 ITGAM ITPR2 LRGUK GTPBP2 SERPINI1 SLC11A1 CLCN3 ATP11B GYG1 MROH2B DIAPH1 PKM DMD DNM1 GNS DYNC1H1 KPNB1 | 3.23e-05 | 1014 | 148 | 20 | GO:0030141 |
| GeneOntologyCellularComponent | GMP reductase complex | 4.98e-05 | 2 | 148 | 2 | GO:1902560 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 5.31e-05 | 185 | 148 | 8 | GO:0101002 | |
| GeneOntologyCellularComponent | secretory vesicle | PSMB7 PSMC3 GRIN2A XRCC5 ITGAM ITPR2 LRGUK GTPBP2 SERPINI1 SLC11A1 CLCN3 ATP11B SPHK1 GYG1 MROH2B DIAPH1 PKM DMD DNM1 GNS DYNC1H1 KPNB1 | 6.66e-05 | 1246 | 148 | 22 | GO:0099503 |
| GeneOntologyCellularComponent | secretory granule lumen | PSMB7 PSMC3 XRCC5 GTPBP2 SERPINI1 GYG1 PKM GNS DYNC1H1 KPNB1 | 1.10e-04 | 325 | 148 | 10 | GO:0034774 |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | PSMB7 PSMC3 XRCC5 GTPBP2 SERPINI1 GYG1 PKM GNS DYNC1H1 KPNB1 | 1.25e-04 | 330 | 148 | 10 | GO:0060205 |
| GeneOntologyCellularComponent | vesicle lumen | PSMB7 PSMC3 XRCC5 GTPBP2 SERPINI1 GYG1 PKM GNS DYNC1H1 KPNB1 | 1.31e-04 | 332 | 148 | 10 | GO:0031983 |
| GeneOntologyCellularComponent | postsynaptic membrane | DGKB GRIN2A SLC6A3 TMUB1 CLCN3 DNM3 GRIN3A CTNNB1 DMD CDH10 DNM2 | 1.50e-04 | 405 | 148 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | photoreceptor inner segment | 2.32e-04 | 78 | 148 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 2.56e-04 | 124 | 148 | 6 | GO:1904813 | |
| GeneOntologyCellularComponent | cell projection membrane | TRPM6 EPB41L5 GRIN2A CLCN3 SLC20A2 DIAPH1 ROBO1 SGCE CTNNB1 DMD DNM2 | 2.57e-04 | 431 | 148 | 11 | GO:0031253 |
| GeneOntologyCellularComponent | synaptic membrane | ANXA1 DGKB GRIN2A SLC6A3 TMUB1 CLCN3 DNM3 GRIN3A CTNNB1 DMD DNM1 CDH10 DNM2 | 2.65e-04 | 583 | 148 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | microtubule organizing center | IFT140 ABCA2 TBC1D30 KIAA0586 MCM3 CUL7 KIF7 TMUB1 CEP78 TUBGCP3 DIAPH1 ZFYVE26 CTNNB1 EXOC7 DYNC1H1 KIFC1 DNM2 | 2.81e-04 | 919 | 148 | 17 | GO:0005815 |
| GeneOntologyCellularComponent | recombination nodule | 2.96e-04 | 4 | 148 | 2 | GO:0005713 | |
| GeneOntologyCellularComponent | actin filament | 6.12e-04 | 146 | 148 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYO1A DYNC2H1 ANXA1 ACTG1 KIF7 SHROOM4 LDB3 TUBGCP3 DIAPH1 DNM3 DMD DNM1 DYNC1H1 MX1 KIFC1 DNM2 | 6.49e-04 | 899 | 148 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH6 MYH10 MYO1A DYNC2H1 ANXA1 ACTG1 KIF7 SHROOM4 LDB3 TUBGCP3 DIAPH1 DNM3 CTNNB1 DMD DNM1 DYNC1H1 MX1 KIFC1 DNM2 | 6.76e-04 | 1179 | 148 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH6 MYH10 MYO1A DYNC2H1 ANXA1 ACTG1 KIF7 SHROOM4 LDB3 TUBGCP3 DIAPH1 DNM3 CTNNB1 DMD DNM1 DYNC1H1 MX1 KIFC1 DNM2 | 7.33e-04 | 1187 | 148 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | leading edge membrane | 7.56e-04 | 210 | 148 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | adherens junction | 7.99e-04 | 212 | 148 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | cell leading edge | MYH10 MYO1A EPB41L5 GRIN2A CLCN3 DIAPH1 ROBO1 SGCE CTNNB1 DMD DNM2 | 8.85e-04 | 500 | 148 | 11 | GO:0031252 |
| GeneOntologyCellularComponent | centrosome | IFT140 KIAA0586 MCM3 CUL7 TMUB1 CEP78 TUBGCP3 DIAPH1 ZFYVE26 CTNNB1 EXOC7 DYNC1H1 KIFC1 DNM2 | 1.16e-03 | 770 | 148 | 14 | GO:0005813 |
| GeneOntologyCellularComponent | matrix side of mitochondrial inner membrane | 1.36e-03 | 8 | 148 | 2 | GO:0099617 | |
| GeneOntologyCellularComponent | condensin complex | 1.36e-03 | 8 | 148 | 2 | GO:0000796 | |
| GeneOntologyCellularComponent | catenin complex | 1.48e-03 | 32 | 148 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | presynapse | FXR2 ACTG1 GRIN2A ZZEF1 SLC6A3 CLCN3 SPHK1 DIAPH1 DNM3 GRIN3A CTNNB1 DMD DNM1 CDH10 DNM2 | 1.58e-03 | 886 | 148 | 15 | GO:0098793 |
| GeneOntologyCellularComponent | axon | MYH10 MYO1A ACTG1 GRIN2A ITPR2 SLC6A3 CLCN3 SPHK1 DNM3 ROBO1 DMD DNM1 EXOC7 DYNC1H1 DNM2 | 1.67e-03 | 891 | 148 | 15 | GO:0030424 |
| GeneOntologyCellularComponent | endocytic vesicle | 1.69e-03 | 384 | 148 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 1.73e-03 | 9 | 148 | 2 | GO:0017146 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 2.16e-03 | 10 | 148 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | flotillin complex | 2.16e-03 | 10 | 148 | 2 | GO:0016600 | |
| GeneOntologyCellularComponent | filamentous actin | 2.45e-03 | 38 | 148 | 3 | GO:0031941 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.51e-03 | 80 | 148 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 3.14e-03 | 12 | 148 | 2 | GO:0031074 | |
| MousePheno | atrioventricular septal defect | 6.04e-06 | 84 | 116 | 7 | MP:0010412 | |
| MousePheno | abnormal atrioventricular septum morphology | 7.63e-06 | 87 | 116 | 7 | MP:0010592 | |
| MousePheno | impaired coordination | MYH10 FXR2 DGKG GRIN2A SLC6A3 LDB3 CLCN3 SGCE ZFYVE26 CTNNB1 DMD HERC1 DNM1 DYNC1H1 | 4.11e-05 | 478 | 116 | 14 | MP:0001405 |
| MousePheno | abnormal heart and great vessel attachment | 5.80e-05 | 208 | 116 | 9 | MP:0010425 | |
| MousePheno | abnormal heart ventricle morphology | IFT140 MYH6 ABCA1 MYH10 NAT8 XPNPEP1 SSR1 MED1 XRCC5 KIF7 OTUD7B LDB3 GYG1 ROBO1 PDS5A DMD KDM1A DNM2 | 8.97e-05 | 793 | 116 | 18 | MP:0005294 |
| MousePheno | abnormal heart septum morphology | IFT140 MYH10 DYNC2H1 NAT8 XPNPEP1 SSR1 KIF7 OTUD7B ROBO1 PDS5A KDM1A DNM2 | 9.01e-05 | 388 | 116 | 12 | MP:0006113 |
| MousePheno | abnormal interventricular septum morphology | IFT140 MYH10 NAT8 XPNPEP1 SSR1 KIF7 OTUD7B ROBO1 PDS5A KDM1A DNM2 | 1.27e-04 | 342 | 116 | 11 | MP:0000281 |
| Domain | P-loop_NTPase | MYH6 ABCA1 ABCA2 MYH10 MYO1A DYNC2H1 NOA1 SMC4 PSMC3 MCM3 MSH4 SRCAP HELQ KIF7 LRGUK GTPBP2 MDN1 ABCE1 HELZ2 DNM3 DDX23 DNM1 DYNC1H1 MX1 KIFC1 DNM2 ATP5F1B | 6.62e-10 | 848 | 149 | 27 | IPR027417 |
| Domain | Dynamin_central | 5.76e-08 | 6 | 149 | 4 | IPR000375 | |
| Domain | GED | 5.76e-08 | 6 | 149 | 4 | SM00302 | |
| Domain | Dynamin_M | 5.76e-08 | 6 | 149 | 4 | PF01031 | |
| Domain | GED_dom | 5.76e-08 | 6 | 149 | 4 | IPR020850 | |
| Domain | GED | 5.76e-08 | 6 | 149 | 4 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 5.76e-08 | 6 | 149 | 4 | IPR019762 | |
| Domain | GED | 5.76e-08 | 6 | 149 | 4 | PF02212 | |
| Domain | GED | 5.76e-08 | 6 | 149 | 4 | IPR003130 | |
| Domain | - | ABCA1 ABCA2 DYNC2H1 NOA1 SMC4 PSMC3 MCM3 MSH4 SRCAP HELQ LRGUK GTPBP2 MDN1 ABCE1 HELZ2 DNM3 DDX23 DNM1 DYNC1H1 MX1 DNM2 ATP5F1B | 1.18e-07 | 746 | 149 | 22 | 3.40.50.300 |
| Domain | G_DYNAMIN_1 | 1.34e-07 | 7 | 149 | 4 | PS00410 | |
| Domain | DYNc | 1.34e-07 | 7 | 149 | 4 | SM00053 | |
| Domain | AAA | ABCA1 ABCA2 DYNC2H1 PSMC3 MCM3 MDN1 ABCE1 HELZ2 DYNC1H1 ATP5F1B | 2.38e-07 | 144 | 149 | 10 | SM00382 |
| Domain | AAA+_ATPase | ABCA1 ABCA2 DYNC2H1 PSMC3 MCM3 MDN1 ABCE1 HELZ2 DYNC1H1 ATP5F1B | 2.38e-07 | 144 | 149 | 10 | IPR003593 |
| Domain | G_DYNAMIN_dom | 3.66e-06 | 14 | 149 | 4 | IPR030381 | |
| Domain | DAGKc | 3.66e-06 | 14 | 149 | 4 | SM00046 | |
| Domain | G_DYNAMIN_2 | 3.66e-06 | 14 | 149 | 4 | PS51718 | |
| Domain | Diacylglycerol_kinase_cat_dom | 4.96e-06 | 15 | 149 | 4 | IPR001206 | |
| Domain | Dynamin_GTPase | 4.96e-06 | 15 | 149 | 4 | IPR001401 | |
| Domain | DAGK | 4.96e-06 | 15 | 149 | 4 | PS50146 | |
| Domain | Dynamin_SF | 4.96e-06 | 15 | 149 | 4 | IPR022812 | |
| Domain | Dynamin_N | 4.96e-06 | 15 | 149 | 4 | PF00350 | |
| Domain | DAGK_cat | 4.96e-06 | 15 | 149 | 4 | PF00781 | |
| Domain | NAD/diacylglycerol_kinase | 8.54e-06 | 17 | 149 | 4 | IPR016064 | |
| Domain | GMPR | 6.32e-05 | 2 | 149 | 2 | IPR005993 | |
| Domain | ATPase_dyneun-rel_AAA | 1.70e-04 | 14 | 149 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.70e-04 | 14 | 149 | 3 | PF07728 | |
| Domain | - | 1.89e-04 | 3 | 149 | 2 | 1.10.238.110 | |
| Domain | DAG_kinase_N | 1.89e-04 | 3 | 149 | 2 | PF14513 | |
| Domain | DAG_kinase_typeI_N | 1.89e-04 | 3 | 149 | 2 | IPR029477 | |
| Domain | IMPDH | 3.75e-04 | 4 | 149 | 2 | PF00478 | |
| Domain | IMP_DH_GMPRt | 3.75e-04 | 4 | 149 | 2 | IPR001093 | |
| Domain | IMP_DH_GMP_RED | 3.75e-04 | 4 | 149 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 3.75e-04 | 4 | 149 | 2 | IPR015875 | |
| Domain | - | 3.75e-04 | 4 | 149 | 2 | 1.10.12.10 | |
| Domain | ARM-type_fold | CUL7 ITPR2 URB1 MROH2B NCAPD2 DIAPH1 PDS5A CTNNB1 KPNB1 KPNA3 | 4.00e-04 | 339 | 149 | 10 | IPR016024 |
| Domain | Crontonase_C | 6.22e-04 | 5 | 149 | 2 | IPR014748 | |
| Domain | - | 6.22e-04 | 5 | 149 | 2 | 2.40.290.10 | |
| Domain | SPOC-like_C_dom | 6.22e-04 | 5 | 149 | 2 | IPR016194 | |
| Domain | SPOC_C | 9.29e-04 | 6 | 149 | 2 | IPR012921 | |
| Domain | SPOC | 9.29e-04 | 6 | 149 | 2 | PF07744 | |
| Domain | APC_su10/DOC_dom | 1.29e-03 | 7 | 149 | 2 | IPR004939 | |
| Domain | DOC | 1.29e-03 | 7 | 149 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.29e-03 | 7 | 149 | 2 | PF03256 | |
| Domain | APC10 | 1.29e-03 | 7 | 149 | 2 | SM01337 | |
| Domain | DHC_N1 | 1.72e-03 | 8 | 149 | 2 | PF08385 | |
| Domain | Enoyl-CoA_hyd/isom_CS | 1.72e-03 | 8 | 149 | 2 | IPR018376 | |
| Domain | Dynein_heavy_dom-1 | 1.72e-03 | 8 | 149 | 2 | IPR013594 | |
| Domain | Arm | 1.90e-03 | 31 | 149 | 3 | PF00514 | |
| Domain | - | 2.06e-03 | 222 | 149 | 7 | 1.25.10.10 | |
| Pubmed | MYH10 HYOU1 FXR2 ANXA1 ANXA6 SMC4 NARS1 PSMC3 ELP1 CUL7 XRCC5 URB1 MDN1 ABCE1 PHF3 NCAPD2 HELZ2 PDCD11 DDX23 ANKRD28 PDS5A ZBTB11 SPEN DYNC1H1 KDM1A DNM2 KPNB1 | 7.15e-19 | 653 | 150 | 27 | 22586326 | |
| Pubmed | MYH10 HYOU1 SMC4 PSMC3 ELP1 MCM3 XRCC5 MDN1 TUBGCP3 NCAPD2 DIAPH1 PKM AGK PDCD11 PDS5A STIP1 CTNNB1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 | 6.47e-14 | 638 | 150 | 22 | 33239621 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 MYH10 HYOU1 DYNC2H1 ANXA6 KIAA0586 SMC4 PSMC3 ELP1 ACTG1 MCM3 SSR1 XRCC5 URB1 MDN1 PMPCA ABCE1 NCAPD2 DIAPH1 PKM AGK PDCD11 PDS5A STIP1 SPEN DYNC1H1 KDM1A KIFC1 ATP5F1B KPNB1 | 4.92e-13 | 1425 | 150 | 30 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAGEA4 MYH10 GNE ANXA1 SMC4 EPB41L5 NARS1 PSMC3 ELP1 MCM3 SRCAP XRCC5 URB1 MDN1 ABCE1 PPM1F TUBGCP3 NCAPD2 DIAPH1 PKM PDCD11 DDX23 ANKRD28 PDS5A DYNC1H1 KDM1A ATP5F1B KPNB1 KPNA3 | 8.24e-13 | 1353 | 150 | 29 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HYOU1 ANXA1 ANXA6 SMC4 ELP1 ACTG1 MCM3 CUL7 SRCAP XRCC5 KIF7 ITPR2 URB1 MDN1 PKM PDCD11 DDX23 STIP1 CTNNB1 SPEN DYNC1H1 KDM1A KIFC1 ATP5F1B KPNB1 | 2.35e-12 | 1024 | 150 | 25 | 24711643 |
| Pubmed | MYH10 HYOU1 FXR2 ANXA6 PSMB7 SMC4 NARS1 PSMC3 ELP1 MCM3 XRCC5 PGM3 ITPR2 URB1 MDN1 NCAPD2 PDCD11 DDX23 ANKRD28 PDS5A STIP1 CTNNB1 EXOC7 GNS DYNC1H1 MX1 ATP5F1B KPNB1 KPNA3 | 3.78e-12 | 1440 | 150 | 29 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HYOU1 GNE ANXA6 PSMB7 SMC4 NARS1 PSMC3 ELP1 ACTG1 MCM3 TUT1 XPNPEP1 GMPR2 XRCC5 ZZEF1 ABCE1 NCAPD2 DIAPH1 PKM ANKRD28 STIP1 HERC1 DNM1 TRIM47 GNS DYNC1H1 ATP5F1B KPNB1 KPNA3 | 4.85e-12 | 1455 | 150 | 29 | 22863883 |
| Pubmed | ABCA2 HYOU1 FXR2 ANXA6 PSMC3 ACTG1 MCM3 MED1 XRCC5 ITPR2 MDN1 CLCN3 ATP11B G6PC3 ABCE1 GYG1 TUBGCP3 NCAPD2 HELZ2 CHPF2 EXOC7 DYNC1H1 KIFC1 ATP5F1B GNPAT KPNB1 | 6.39e-12 | 1168 | 150 | 26 | 19946888 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH6 MYH10 HYOU1 MYO1A ANXA1 SMC4 PSMC3 SSR1 XRCC5 MDN1 NCAPD2 PKM AGK CTNNB1 EXOC7 DYNC1H1 MX1 DNM2 ATP5F1B KPNB1 | 7.05e-12 | 647 | 150 | 20 | 26618866 |
| Pubmed | ZNF143 HYOU1 NOA1 ELP1 ZZEF1 CEMIP GTPBP2 CLCN3 CEP78 ABCE1 TUBGCP3 ANKRD28 CHPF2 DNM1 EXOC7 ZBTB11 KIFC1 DNM2 GNPAT ZNF574 | 7.66e-12 | 650 | 150 | 20 | 38777146 | |
| Pubmed | TRPM6 MYH10 FXR2 ANXA6 NARS1 ACTG1 MCM3 GMPR2 XRCC5 PGM3 ABCE1 PKM STIP1 CTNNB1 DHTKD1 KPNB1 | 1.38e-10 | 451 | 150 | 16 | 36168627 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PSMB7 SMC4 PSMC3 ELP1 ACTG1 MCM3 SSR1 XRCC5 PGM3 URB1 MDN1 PMPCA ABCE1 PPM1F PKM AGK DDX23 LRRC14 CTNNB1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 KPNA3 | 1.83e-10 | 1257 | 150 | 25 | 37317656 |
| Pubmed | TRERF1 MYH10 FXR2 PAK5 MCM3 GRIN2A XRCC5 KIF7 SIRPG MDN1 DIAPH1 DNM3 ANKRD28 STIP1 PLCL1 CTNNB1 DNM1 CDH10 DYNC1H1 KDM1A DNM2 KPNB1 | 1.96e-10 | 963 | 150 | 22 | 28671696 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SMC4 NARS1 PSMC3 MCM3 XPNPEP1 SRCAP XRCC5 MDN1 PHF3 NCAPD2 PKM PDS5A STIP1 DYNC1H1 | 2.21e-10 | 332 | 150 | 14 | 32786267 |
| Pubmed | ANXA1 ANXA6 SMC4 PSMC3 MCM3 MDN1 NCAPD2 PKM ROBO1 ANKRD28 PDS5A STIP1 CTNNB1 DYNC1H1 KDM1A | 2.41e-10 | 399 | 150 | 15 | 37536630 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 MYH10 HYOU1 DYNC2H1 ANXA1 PSMC3 MCM3 XPNPEP1 SRCAP XRCC5 ZZEF1 MDN1 ABCE1 DIAPH1 PKM STIP1 DYNC1H1 DNM2 ATP5F1B KPNB1 | 3.48e-10 | 807 | 150 | 20 | 30575818 |
| Pubmed | TRERF1 ZNF143 HYOU1 ANXA1 ANXA6 PSMB7 SMC4 NARS1 PSMC3 ACTG1 MED1 CCDC12 ABCE1 TUBGCP3 PKM DDX23 PDS5A SPEN DYNC1H1 KDM1A KIFC1 DNM2 KPNB1 | 4.30e-10 | 1103 | 150 | 23 | 34189442 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | MYH10 FXR2 PSMC3 ACTG1 MCM3 SSR1 XRCC5 PGM3 ABCE1 PPM1F PKM AGK DYNC1H1 DNM2 ATP5F1B KPNB1 HSP90AB3P | 4.43e-10 | 565 | 150 | 17 | 33567341 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH10 ANXA6 PSMB7 SMC4 NARS1 PSMC3 ACTG1 MCM3 SRCAP XRCC5 MDN1 NCAPD2 DNM3 DDX23 EXOC7 DYNC1H1 DNM2 ATP5F1B KPNB1 HSP90AB3P | 8.02e-10 | 847 | 150 | 20 | 35235311 |
| Pubmed | MYH10 FXR2 SMC4 ACTG1 MCM3 MED1 XRCC5 PGM3 ABCE1 PKM DDX23 DNM2 ATP5F1B KPNB1 KPNA3 | 9.50e-10 | 441 | 150 | 15 | 31239290 | |
| Pubmed | HYOU1 SMC4 PSMC3 ACTG1 MCM3 TUT1 SSR1 ABCE1 PPM1F PKM AGK ANKRD28 CHPF2 GNS DNM2 ATP5F1B KPNB1 | 1.52e-09 | 613 | 150 | 17 | 22268729 | |
| Pubmed | MYH10 HYOU1 ANXA1 PSMB7 SMC4 PSMC3 MCM3 XRCC5 MDN1 DIAPH1 PKM STIP1 DMD DYNC1H1 KPNB1 HSP90AB3P | 1.76e-09 | 538 | 150 | 16 | 28524877 | |
| Pubmed | SMC4 ELP1 PGM3 TUBGCP3 NCAPD2 DIAPH1 AGK DDX23 ANKRD28 PDS5A EXOC7 DYNC1H1 KDM1A DNM2 GNPAT KPNB1 | 3.11e-09 | 560 | 150 | 16 | 35241646 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | MYH10 SMC4 NARS1 ACTG1 ITGAM MDN1 HELZ2 DIAPH1 PKM DYNC1H1 DNM2 ATP5F1B KPNB1 | 3.75e-09 | 344 | 150 | 13 | 30333137 |
| Pubmed | MYH10 HYOU1 ANXA1 PSMC3 MCM3 XRCC5 DIAPH1 PKM PDS5A STIP1 CTNNB1 KDM1A KIFC1 KPNB1 KPNA3 | 4.41e-09 | 494 | 150 | 15 | 26831064 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH10 HYOU1 FXR2 ANXA1 PSMB7 SMC4 NARS1 PSMC3 MCM3 XRCC5 MDN1 NCAPD2 DIAPH1 PKM PDS5A STIP1 EXOC7 DYNC1H1 DNM2 ATP5F1B KPNB1 KPNA3 | 5.08e-09 | 1149 | 150 | 22 | 35446349 |
| Pubmed | MYH10 AUH FXR2 ANXA1 ANXA6 EPB41L5 NARS1 ELP1 MED1 XRCC5 CEP78 PHF3 TUBGCP3 HELZ2 PKM AGK PDCD11 DDX23 CTNNB1 CDKN2AIPNL DYNC1H1 ATP5F1B ZNF574 KPNA3 | 5.40e-09 | 1371 | 150 | 24 | 36244648 | |
| Pubmed | MYH10 GNE FXR2 MCM3 XRCC5 ABCE1 TUBGCP3 HELZ2 PKM DMD DYNC1H1 KPNB1 | 7.56e-09 | 298 | 150 | 12 | 30737378 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 ANXA1 ANXA6 SHBG NARS1 ACTG1 XPNPEP1 SERPINA6 CPNE5 ITGAM SERPINI1 PKM DNM3 DNM1 GNS DYNC1H1 CDH15 DNM2 ATP5F1B KPNB1 HSP90AB3P | 7.67e-09 | 1070 | 150 | 21 | 23533145 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MAGEA4 MYH10 ANXA1 PSMC3 ACTG1 MCM3 XRCC5 URB1 MDN1 PHF3 PKM PDCD11 DDX23 CTNNB1 ZBTB11 CDKN2AIPNL KDM1A KIFC1 ATP5F1B KPNB1 | 1.10e-08 | 989 | 150 | 20 | 36424410 |
| Pubmed | 1.24e-08 | 142 | 150 | 9 | 30809309 | ||
| Pubmed | HYOU1 SMC4 EPB41L5 NARS1 MCM3 XPNPEP1 XRCC5 ABCE1 NCAPD2 PKM AGK ROBO1 PDS5A STIP1 DYNC1H1 ATP5F1B KPNB1 | 1.28e-08 | 708 | 150 | 17 | 39231216 | |
| Pubmed | 1.59e-08 | 197 | 150 | 10 | 31620119 | ||
| Pubmed | MYH10 PSMB7 SMC4 PSMC3 ACTG1 SSR1 NCAPD2 PKM AGK KDM1A ATP5F1B KPNB1 | 1.67e-08 | 320 | 150 | 12 | 28685749 | |
| Pubmed | MYH10 FXR2 SMC4 NARS1 PSMC3 ACTG1 MCM3 MED1 XRCC5 ABCE1 PHF3 DIAPH1 PKM ANKRD28 STIP1 CTNNB1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 KPNA3 | 2.20e-08 | 1247 | 150 | 22 | 27684187 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | HYOU1 DYNC2H1 PSMB7 SMC4 PSMC3 ELP1 SSR1 PGM3 TMUB1 URB1 CEP78 PPM1F NCAPD2 PDS5A CHPF2 CTNNB1 EXOC7 DYNC1H1 KPNB1 | 2.75e-08 | 942 | 150 | 19 | 31073040 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.19e-08 | 212 | 150 | 10 | 33853758 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HYOU1 FXR2 PSMB7 SMC4 EPB41L5 PSMC3 ELP1 PTPN21 PGM3 KIF7 PMPCA ABCE1 ANKRD28 STIP1 DMD KDM1A ATP5F1B KPNB1 HSP90AB3P | 4.64e-08 | 974 | 150 | 19 | 28675297 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH10 ANXA6 MCM3 SSR1 MED1 SRCAP XRCC5 TUBGCP3 HELZ2 PKM DNM3 AGK DDX23 PDS5A DNM1 SPEN GNS DYNC1H1 KPNB1 KPNA3 | 4.81e-08 | 1082 | 150 | 20 | 38697112 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MYH10 HYOU1 FXR2 SMC4 NARS1 PSMC3 MCM3 CCDC12 XRCC5 MDN1 G6PC3 ABCE1 DIAPH1 PKM PDCD11 DDX23 STIP1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 | 5.80e-08 | 1318 | 150 | 22 | 30463901 |
| Pubmed | FXR2 DYNC2H1 NLRX1 ELP1 KIF7 MDN1 PMPCA PPM1F NCAPD2 DDX23 ANKRD28 PDS5A EXOC7 DNM2 KPNA3 | 6.52e-08 | 606 | 150 | 15 | 36538041 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | SMC4 NARS1 ELP1 MCM3 MED1 CCDC12 XRCC5 ITPR2 ABCE1 HELZ2 PKM AGK KDM1A DNM2 ATP5F1B KPNA3 | 7.04e-08 | 701 | 150 | 16 | 30196744 |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 12511974 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 24273169 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 12383797 | ||
| Pubmed | Developmental expression of the dynamin family of mechanoenzymes in the mouse epididymis. | 7.86e-08 | 3 | 150 | 3 | 28395327 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 12517701 | ||
| Pubmed | Dynamin triple knockout cells reveal off target effects of commonly used dynamin inhibitors. | 7.86e-08 | 3 | 150 | 3 | 24046449 | |
| Pubmed | 9.08e-08 | 237 | 150 | 10 | 29564676 | ||
| Pubmed | HYOU1 GNE PSMB7 PSMC3 XRCC5 TMUB1 PMPCA ABCE1 AGK CTNNB1 MMUT DYNC1H1 DNM2 KPNA3 | 9.09e-08 | 534 | 150 | 14 | 35032548 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MAGEA4 MYH10 HYOU1 FXR2 ANXA1 SMC4 NARS1 MCM3 XRCC5 ITPR2 PHF3 HELZ2 PKM AGK PDCD11 CTNNB1 SPEN DYNC1H1 KIFC1 ATP5F1B KPNB1 | 1.18e-07 | 1257 | 150 | 21 | 36526897 |
| Pubmed | ZNF143 FXR2 DYNC2H1 ANXA6 ELP1 SSR1 MED1 KIF7 MDN1 ABCE1 PPM1F AGK SPEN UTY DNM2 | 1.27e-07 | 638 | 150 | 15 | 31182584 | |
| Pubmed | SMC4 ACTG1 MCM3 MED1 SRCAP MBIP PHF3 NCAPD2 PKM PDCD11 SPEN DYNC1H1 KDM1A KPNB1 | 1.27e-07 | 549 | 150 | 14 | 38280479 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | MYH10 PAK5 DGKG MCM3 XRCC5 PKM DMD DNM1 DYNC1H1 ATP5F1B KPNB1 | 1.47e-07 | 317 | 150 | 11 | 17620599 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MYH10 FXR2 SMC4 MED1 SRCAP XRCC5 MDN1 PDCD11 DDX23 PDS5A EXOC7 DNM2 | 1.60e-07 | 394 | 150 | 12 | 27248496 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MYH10 FXR2 FRS3 PSMC3 ACTG1 GRIN2A MBIP KIF7 FBLN2 SERPINI1 PKM CTNNB1 MX1 DNM2 | 1.62e-07 | 560 | 150 | 14 | 21653829 |
| Pubmed | 1.68e-07 | 93 | 150 | 7 | 22079093 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | MYH10 HYOU1 FXR2 ANXA1 SMC4 NARS1 PSMC3 ELP1 ACTG1 MCM3 SSR1 XRCC5 NCAPD2 DIAPH1 PKM DDX23 PDS5A STIP1 TRIM47 DYNC1H1 ATP5F1B KPNB1 | 1.97e-07 | 1415 | 150 | 22 | 28515276 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SFMBT1 MYH10 ZNF143 MYO1A SMC4 E4F1 CUL7 KIF7 MDN1 NCAPD2 PKM ANKRD28 PDS5A CTNNB1 SPEN DYNC1H1 KDM1A | 1.97e-07 | 857 | 150 | 17 | 25609649 |
| Pubmed | MAGEA4 MYH10 HYOU1 FXR2 ANXA1 NARS1 MCM3 PKM STIP1 ATP5F1B KPNB1 | 2.00e-07 | 327 | 150 | 11 | 31409639 | |
| Pubmed | MYH6 MYH10 HYOU1 ANXA1 NARS1 PSMC3 ELP1 ACTG1 DGKB GRIN2A ITPR2 PKM STIP1 PLCL1 CTNNB1 DMD DNM1 DYNC1H1 DNM2 ATP5F1B KPNB1 KPNA3 | 2.39e-07 | 1431 | 150 | 22 | 37142655 | |
| Pubmed | TBC1D30 DYNC2H1 KIAA0586 EPB41L5 CUL7 SHROOM4 LDB3 HELZ2 PDS5A LRRC14 GRIN3A EXOC7 DHTKD1 | 2.50e-07 | 493 | 150 | 13 | 15368895 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MYH10 HYOU1 PSMB7 PSMC3 ELP1 MCM3 XRCC5 DIAPH1 PKM STIP1 ATP5F1B KPNB1 KPNA3 | 2.62e-07 | 495 | 150 | 13 | 28581483 |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 2.76e-07 | 100 | 150 | 7 | 25807483 | |
| Pubmed | Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. | 3.14e-07 | 4 | 150 | 3 | 21689597 | |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 22846998 | ||
| Pubmed | ABCA2 HYOU1 NOA1 PSMB7 PSMC3 ELP1 MCM3 TUT1 SSR1 XRCC5 CEP78 PMPCA GYG1 PKM ANKRD28 STIP1 KDM1A ATP5F1B KPNB1 KPNA3 HSP90AB3P | 3.18e-07 | 1335 | 150 | 21 | 29229926 | |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | PSMC3 ACTG1 MCM3 XRCC5 PGM3 DIAPH1 PKM DYNC1H1 ATP5F1B KPNB1 HSP90AB3P | 3.31e-07 | 344 | 150 | 11 | 36282215 |
| Pubmed | 3.61e-07 | 104 | 150 | 7 | 36055981 | ||
| Pubmed | Identification of atrogin-1-targeted proteins during the myostatin-induced skeletal muscle wasting. | 4.00e-07 | 155 | 150 | 8 | 22673621 | |
| Pubmed | ANXA1 PSMB7 SMC4 NARS1 MCM3 MED1 CCDC12 XRCC5 MDN1 ABCE1 PHF3 NCAPD2 DIAPH1 DDX23 PDS5A CTNNB1 CDKN2AIPNL KDM1A | 4.28e-07 | 1014 | 150 | 18 | 32416067 | |
| Pubmed | MYH10 ANXA1 ANXA6 SMC4 NARS1 PSMC3 DGKG MCM3 XRCC5 ABCE1 HELZ2 PKM STIP1 DYNC1H1 ATP5F1B KPNB1 | 4.35e-07 | 803 | 150 | 16 | 36517590 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAGEA4 MYH10 HYOU1 ANXA1 ANXA6 SMC4 XPNPEP1 SSR1 XRCC5 ITGAM ABCE1 GYG1 NCAPD2 PKM PDCD11 STIP1 CTNNB1 GNS MMUT ATP5F1B KPNB1 | 4.67e-07 | 1367 | 150 | 21 | 32687490 |
| Pubmed | 4.71e-07 | 217 | 150 | 9 | 30619736 | ||
| Pubmed | MYH10 SMC4 ACTG1 MCM3 XRCC5 MDN1 ABCE1 NCAPD2 PKM CTNNB1 DMD DYNC1H1 KDM1A KIFC1 ATP5F1B KPNB1 | 4.80e-07 | 809 | 150 | 16 | 32129710 | |
| Pubmed | HYOU1 FXR2 NARS1 PSMC3 ACTG1 XRCC5 ABCE1 DIAPH1 PKM AGK PDCD11 CTNNB1 DYNC1H1 DNM2 ATP5F1B | 5.00e-07 | 711 | 150 | 15 | 33022573 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYH10 HYOU1 AUH FXR2 NOA1 PSMB7 PSMC3 ELP1 CUL7 XRCC5 ZZEF1 ITPR2 MDN1 PMPCA ABCE1 AGK PDCD11 STIP1 HERC1 DHTKD1 MMUT ATP5F1B | 5.04e-07 | 1496 | 150 | 22 | 32877691 |
| Pubmed | TBC1D30 NOA1 SMC4 EPB41L5 E4F1 SSR1 MED1 URB1 MDN1 PHF3 NCAPD2 HELZ2 PDCD11 PDS5A STIP1 ZBTB11 SPEN KDM1A KIFC1 ATP5F1B ZNF574 KPNA3 | 5.10e-07 | 1497 | 150 | 22 | 31527615 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | FXR2 TSPYL2 ELP1 MCM3 MED1 SRCAP XRCC5 ITPR2 PHF3 CTNNB1 ZBTB11 KDM1A | 5.18e-07 | 440 | 150 | 12 | 34244565 |
| Pubmed | MYH10 HYOU1 PSMC3 ELP1 ACTG1 PTPN21 CUL7 KIF7 ITPR2 PMPCA PPM1F ROBO1 ANKRD28 STIP1 DMD HERC1 KPNB1 KPNA3 | 6.97e-07 | 1049 | 150 | 18 | 27880917 | |
| Pubmed | MYH10 HYOU1 FXR2 ANXA1 CUL7 XRCC5 MDN1 PDCD11 ANKRD28 PDS5A CTNNB1 CDKN2AIPNL DNM2 KPNA3 | 7.16e-07 | 634 | 150 | 14 | 34591612 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TBC1D30 FXR2 SMC4 NARS1 XRCC5 ZZEF1 ITPR2 URB1 MDN1 ABCE1 PKM PDS5A STIP1 ZBTB11 DYNC1H1 | 7.70e-07 | 736 | 150 | 15 | 29676528 |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 9722593 | ||
| Pubmed | MYH10 HYOU1 FXR2 NOA1 SMC4 PSMC3 ACTG1 SSR1 XRCC5 DIAPH1 PDCD11 ROBO1 PDS5A STIP1 CTNNB1 GNS DYNC1H1 DNM2 KPNB1 KPNA3 | 8.49e-07 | 1297 | 150 | 20 | 33545068 | |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 9.70e-07 | 18 | 150 | 4 | 25363768 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.00e-06 | 175 | 150 | 8 | 25756610 | |
| Pubmed | Proteomic identification of brain proteins that interact with dynein light chain LC8. | 1.04e-06 | 42 | 150 | 5 | 14760703 | |
| Pubmed | 1.09e-06 | 177 | 150 | 8 | 26485645 | ||
| Pubmed | MYH6 MYH10 HYOU1 MYO1A SMC4 ACTG1 PTPN21 SRCAP XRCC5 LRRC43 MDN1 CLCN3 PMPCA NCAPD2 PKM DDX23 DMD ZBTB11 SPEN ATP5F1B KPNB1 | 1.10e-06 | 1442 | 150 | 21 | 35575683 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | ANXA1 PSMC3 SSR1 URB1 PMPCA NCAPD2 PKM CTNNB1 DYNC1H1 ATP5F1B GNPAT KPNB1 KPNA3 | 1.30e-06 | 571 | 150 | 13 | 37167062 |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 27251629 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 23640057 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 18602423 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SMC4 PSMC3 ELP1 MDN1 TUBGCP3 NCAPD2 DIAPH1 DDX23 EXOC7 DYNC1H1 KDM1A DNM2 KPNB1 | 1.60e-06 | 582 | 150 | 13 | 20467437 |
| Pubmed | MYH10 ANXA1 ACTG1 MCM3 XRCC5 ABCE1 PKM STIP1 DYNC1H1 DNM2 ATP5F1B KPNB1 | 1.63e-06 | 491 | 150 | 12 | 22623428 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH10 MYO1A FXR2 DYNC2H1 ANXA1 PSMC3 TUT1 KIF7 OTUD7B PMPCA ABCE1 TUBGCP3 DDX23 ANKRD28 STIP1 LRRC14 KPNA3 | 1.76e-06 | 1005 | 150 | 17 | 19615732 |
| Pubmed | 1.82e-06 | 329 | 150 | 10 | 35562734 | ||
| Pubmed | MYH10 FLT4 ACTG1 E4F1 ZZEF1 DIAPH1 ANKRD28 CTNNB1 HERC1 ZBTB11 DYNC1H1 DNM2 KPNB1 | 1.89e-06 | 591 | 150 | 13 | 15231748 | |
| Pubmed | ANXA1 NOA1 ANXA6 SMC4 MCM3 CCDC12 DNM3 AGK ROBO1 ANKRD28 PDS5A STIP1 CTNNB1 DMD KDM1A DNM2 | 2.41e-06 | 916 | 150 | 16 | 32203420 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SMC4 NARS1 PSMC3 ELP1 MCM3 SSR1 GMPR2 PGM3 ABCE1 PKM PDCD11 PDS5A DYNC1H1 KDM1A | 2.43e-06 | 704 | 150 | 14 | 29955894 |
| Interaction | SIRT7 interactions | MYH10 HYOU1 FXR2 ANXA1 ANXA6 SMC4 NARS1 PSMC3 ELP1 CUL7 XRCC5 URB1 MDN1 ABCE1 PHF3 NCAPD2 HELZ2 PDCD11 DDX23 ANKRD28 PDS5A ZBTB11 SPEN DYNC1H1 KDM1A DNM2 KPNB1 | 7.65e-12 | 744 | 150 | 27 | int:SIRT7 |
| Interaction | EPAS1 interactions | PSMC3 ELP1 MCM3 MED1 XRCC5 OTUD7B DDX23 CTNNB1 KDM1A KPNB1 KPNA3 | 7.20e-08 | 173 | 150 | 11 | int:EPAS1 |
| Interaction | MOB3C interactions | ANXA1 ANXA6 SMC4 PSMC3 MCM3 PTPN21 MDN1 NCAPD2 PKM ROBO1 PDS5A STIP1 CTNNB1 DYNC1H1 KDM1A | 9.52e-08 | 364 | 150 | 15 | int:MOB3C |
| Interaction | STIP1 interactions | MYH10 HYOU1 SMC4 PSMC3 ELP1 MCM3 CUL7 XRCC5 PGM3 MDN1 TUBGCP3 NCAPD2 DIAPH1 PKM AGK PDCD11 PDS5A STIP1 CTNNB1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 HSP90AB3P | 1.06e-07 | 1006 | 150 | 25 | int:STIP1 |
| Interaction | HDAC2 interactions | SFMBT1 MYH10 GNE FXR2 SMC4 NARS1 MCM3 CUL7 XRCC5 ABCE1 TUBGCP3 NCAPD2 HELZ2 PKM STIP1 CTNNB1 DMD SPEN GNS DYNC1H1 KDM1A KPNB1 KPNA3 | 1.10e-07 | 865 | 150 | 23 | int:HDAC2 |
| Interaction | CEBPA interactions | TRERF1 ZNF143 HYOU1 ANXA1 ANXA6 PSMB7 SMC4 NARS1 PSMC3 ACTG1 MED1 CCDC12 XRCC5 URB1 ABCE1 TUBGCP3 PKM PDCD11 DDX23 PDS5A GRIN3A CTNNB1 SPEN DYNC1H1 KDM1A KIFC1 DNM2 KPNB1 | 1.31e-07 | 1245 | 150 | 28 | int:CEBPA |
| Interaction | ATG16L1 interactions | KIAA0586 SMC4 NARS1 PSMC3 ELP1 MCM3 MED1 CCDC12 XRCC5 KIF7 ITPR2 CEP78 ABCE1 TUBGCP3 HELZ2 PKM AGK ROBO1 HERC1 TRIM47 KDM1A KIFC1 DNM2 ATP5F1B KPNB1 KPNA3 | 4.29e-07 | 1161 | 150 | 26 | int:ATG16L1 |
| Interaction | BIRC3 interactions | HYOU1 DYNC2H1 ANXA6 KIAA0586 SMC4 PSMC3 ACTG1 MCM3 SSR1 XRCC5 URB1 MDN1 PMPCA ABCE1 SPHK1 NCAPD2 DIAPH1 PKM AGK PDCD11 PDS5A STIP1 SPEN DYNC1H1 KDM1A KIFC1 ATP5F1B KPNB1 | 5.34e-07 | 1334 | 150 | 28 | int:BIRC3 |
| Interaction | ARHGAP24 interactions | TRPM6 MYH10 FXR2 ANXA6 NARS1 ACTG1 MCM3 GMPR2 XRCC5 PGM3 ABCE1 PKM STIP1 CTNNB1 DHTKD1 KPNB1 | 7.22e-07 | 486 | 150 | 16 | int:ARHGAP24 |
| Interaction | HECTD1 interactions | MYH10 FXR2 ANXA1 SMC4 EPB41L5 CUL7 MED1 XRCC5 URB1 MDN1 CEP78 PHF3 TUBGCP3 NCAPD2 DNM3 AGK PDCD11 ANKRD28 STIP1 CTNNB1 EXOC7 ZBTB11 KIFC1 | 1.05e-06 | 984 | 150 | 23 | int:HECTD1 |
| Interaction | ANKRD55 interactions | MYH10 FRS3 PSMC3 MCM3 SSR1 MDN1 PKM PDCD11 DYNC1H1 DNM2 ATP5F1B | 1.15e-06 | 228 | 150 | 11 | int:ANKRD55 |
| Interaction | LINC01554 interactions | 1.19e-06 | 142 | 150 | 9 | int:LINC01554 | |
| Interaction | FBXO32 interactions | MYH6 ANXA1 SMC4 PSMC3 ELP1 ACTG1 LDB3 FBLN2 PMPCA PPM1F TUBGCP3 PKM DNM2 ATP5F1B | 1.20e-06 | 386 | 150 | 14 | int:FBXO32 |
| Interaction | YAP1 interactions | TRERF1 MYH10 HYOU1 MYO1A TSPYL2 SMC4 PSMC3 ACTG1 MCM3 PTPN21 MED1 SRCAP XRCC5 OTUD7B PHF3 PKM STIP1 CTNNB1 SPEN DYNC1H1 KDM1A ATP5F1B KPNB1 HSP90AB3P | 1.85e-06 | 1095 | 150 | 24 | int:YAP1 |
| Interaction | CCDC8 interactions | ANXA6 SMC4 ELP1 ACTG1 MCM3 CUL7 XRCC5 KIF7 ITPR2 MDN1 PKM PDCD11 STIP1 CTNNB1 DYNC1H1 KIFC1 ATP5F1B KPNB1 | 1.94e-06 | 656 | 150 | 18 | int:CCDC8 |
| Interaction | KCNA3 interactions | HYOU1 SMC4 EPB41L5 NARS1 MCM3 XPNPEP1 XRCC5 HELQ ABCE1 PHF3 NCAPD2 PKM AGK ROBO1 PDS5A STIP1 DNM1 SPEN DYNC1H1 ATP5F1B KPNB1 | 2.01e-06 | 871 | 150 | 21 | int:KCNA3 |
| Interaction | SUMO2 interactions | ANXA1 SMC4 NARS1 PSMC3 MCM3 XPNPEP1 SRCAP XRCC5 MDN1 CEP78 PHF3 NCAPD2 PKM PDS5A STIP1 DYNC1H1 KDM1A | 2.03e-06 | 591 | 150 | 17 | int:SUMO2 |
| Interaction | CIT interactions | MYH10 FXR2 DYNC2H1 ANXA1 SMC4 NARS1 PSMC3 MCM3 CUL7 GMPR2 MED1 XRCC5 CPNE5 ZZEF1 URB1 MROH2B PDCD11 DDX23 PDS5A CTNNB1 HERC1 DYNC1H1 KDM1A ATP5F1B ZNF574 KPNB1 KPNA3 HSP90AB3P | 2.75e-06 | 1450 | 150 | 28 | int:CIT |
| Interaction | ZBBX interactions | 3.11e-06 | 31 | 150 | 5 | int:ZBBX | |
| Interaction | OBSL1 interactions | FXR2 ANXA1 PAK5 PSMB7 MCM3 PTPN21 CUL7 SRCAP XRCC5 URB1 MDN1 PKM PDCD11 DDX23 CTNNB1 SPEN CDKN2AIPNL DYNC1H1 KDM1A ATP5F1B KPNB1 | 3.48e-06 | 902 | 150 | 21 | int:OBSL1 |
| Interaction | ZNF598 interactions | MYH10 FXR2 PAK5 PSMB7 SMC4 PSMC3 ACTG1 SSR1 NCAPD2 PKM AGK KDM1A ATP5F1B KPNB1 | 4.81e-06 | 435 | 150 | 14 | int:ZNF598 |
| Interaction | NPHP1 interactions | 5.90e-06 | 130 | 150 | 8 | int:NPHP1 | |
| Interaction | AGR2 interactions | ABCA2 MYH10 HYOU1 DYNC2H1 ANXA1 PSMC3 MCM3 XPNPEP1 SRCAP XRCC5 ZZEF1 MDN1 ABCE1 DIAPH1 PKM STIP1 CDKN2AIPNL DYNC1H1 DNM2 ATP5F1B KPNB1 | 5.96e-06 | 934 | 150 | 21 | int:AGR2 |
| Interaction | GYPA interactions | 6.34e-06 | 174 | 150 | 9 | int:GYPA | |
| Interaction | FBXO6 interactions | ABCA2 HYOU1 SMC4 PSMC3 ACTG1 MCM3 TUT1 SSR1 ABCE1 PPM1F PKM AGK ANKRD28 CHPF2 GNS DNM2 ATP5F1B KPNB1 | 6.67e-06 | 717 | 150 | 18 | int:FBXO6 |
| Interaction | SCN2B interactions | 7.03e-06 | 95 | 150 | 7 | int:SCN2B | |
| Interaction | DHTKD1 interactions | 7.37e-06 | 63 | 150 | 6 | int:DHTKD1 | |
| Interaction | EED interactions | MYH10 HYOU1 FXR2 SMC4 ELP1 ACTG1 MCM3 XPNPEP1 CUL7 XRCC5 URB1 VILL ABCE1 PPM1F TUBGCP3 NCAPD2 PKM AGK PDCD11 PDS5A CTNNB1 SPEN DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 | 7.83e-06 | 1445 | 150 | 27 | int:EED |
| Interaction | NR3C1 interactions | ZNF143 HYOU1 FXR2 DYNC2H1 ANXA6 ELP1 ACTG1 SSR1 MED1 KIF7 MDN1 ABCE1 PPM1F AGK CTNNB1 SPEN UTY KDM1A DNM2 ATP5F1B KPNB1 | 1.13e-05 | 974 | 150 | 21 | int:NR3C1 |
| Interaction | PARP1 interactions | MYH10 HYOU1 ANXA1 SMC4 NARS1 MCM3 E4F1 CUL7 MED1 SRCAP XRCC5 PGM3 URB1 NADSYN1 MDN1 PHF3 NCAPD2 PDCD11 PDS5A STIP1 CTNNB1 DNM1 KIFC1 DNM2 KPNA3 | 1.35e-05 | 1316 | 150 | 25 | int:PARP1 |
| Interaction | PARD6B interactions | 1.38e-05 | 146 | 150 | 8 | int:PARD6B | |
| Interaction | C9orf72 interactions | PSMB7 SMC4 PSMC3 ELP1 ACTG1 MCM3 SSR1 XRCC5 PGM3 URB1 MDN1 PMPCA ABCE1 PPM1F PKM AGK DDX23 LRRC14 CTNNB1 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 KPNA3 | 1.41e-05 | 1319 | 150 | 25 | int:C9orf72 |
| Interaction | C9orf78 interactions | SMC4 ELP1 PGM3 TUBGCP3 NCAPD2 DIAPH1 AGK DDX23 ANKRD28 PDS5A EXOC7 DYNC1H1 KDM1A DNM2 GNPAT KPNB1 | 1.60e-05 | 620 | 150 | 16 | int:C9orf78 |
| Interaction | CDC5L interactions | ANXA1 SMC4 PSMC3 ELP1 MCM3 CUL7 CCDC12 MDN1 TUBGCP3 NCAPD2 DIAPH1 DDX23 STIP1 EXOC7 SPEN DYNC1H1 KDM1A DNM2 KPNB1 | 2.03e-05 | 855 | 150 | 19 | int:CDC5L |
| Interaction | CD6 interactions | 2.04e-05 | 154 | 150 | 8 | int:CD6 | |
| Interaction | EFTUD2 interactions | MYH10 FXR2 ANXA1 SMC4 NARS1 PSMC3 ELP1 ACTG1 MCM3 SSR1 CUL7 CCDC12 XRCC5 NCAPD2 DIAPH1 PKM AGK DDX23 PDS5A STIP1 CTNNB1 TRIM47 DYNC1H1 KDM1A ATP5F1B KPNB1 | 2.39e-05 | 1449 | 150 | 26 | int:EFTUD2 |
| Interaction | ACBD3 interactions | 2.50e-05 | 259 | 150 | 10 | int:ACBD3 | |
| Interaction | TRAF4 interactions | 2.64e-05 | 208 | 150 | 9 | int:TRAF4 | |
| Interaction | EGLN3 interactions | KIAA0586 SMC4 PSMC3 ELP1 MCM3 SSR1 PGM3 KIF7 ABCE1 PHF3 TUBGCP3 PKM AGK ROBO1 ANKRD28 STIP1 CTNNB1 EXOC7 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 KPNA3 | 3.12e-05 | 1296 | 150 | 24 | int:EGLN3 |
| Interaction | CFTR interactions | MYH6 MYH10 HYOU1 MYO1A ANXA1 SMC4 PSMC3 ACTG1 MSH4 SSR1 XRCC5 MDN1 CLCN3 NCAPD2 DIAPH1 PKM AGK ZFYVE26 CTNNB1 DMD EXOC7 DYNC1H1 MX1 DNM2 ATP5F1B KPNB1 | 3.43e-05 | 1480 | 150 | 26 | int:CFTR |
| Interaction | TRIM33 interactions | MYH10 HYOU1 PSMB7 SMC4 ELP1 MCM3 XRCC5 CEP78 ANKRD28 TGM7 STIP1 CTNNB1 ZBTB11 | 3.53e-05 | 453 | 150 | 13 | int:TRIM33 |
| Interaction | BAP1 interactions | MYH10 HYOU1 FXR2 ANXA1 PSMB7 SMC4 NARS1 PSMC3 MCM3 XRCC5 MDN1 NCAPD2 DIAPH1 PKM PDS5A STIP1 CTNNB1 EXOC7 DYNC1H1 KDM1A DNM2 ATP5F1B KPNB1 KPNA3 | 3.89e-05 | 1314 | 150 | 24 | int:BAP1 |
| Interaction | SPRTN interactions | FXR2 PSMC3 ACTG1 MCM3 SSR1 PGM3 ABCE1 PPM1F PKM AGK DYNC1H1 DNM2 ATP5F1B KPNB1 HSP90AB3P | 3.98e-05 | 596 | 150 | 15 | int:SPRTN |
| Interaction | BRCA1 interactions | MYH10 HYOU1 FXR2 ANXA1 PSMC3 ACTG1 MCM3 XRCC5 MDN1 DIAPH1 PKM DDX23 ANKRD28 PDS5A STIP1 CTNNB1 HERC1 TRIM47 DYNC1H1 KDM1A KIFC1 KPNB1 KPNA3 | 5.07e-05 | 1249 | 150 | 23 | int:BRCA1 |
| Interaction | AURKB interactions | MYH10 HYOU1 MYO1A PSMC3 CUL7 XRCC5 ZZEF1 TUBGCP3 NCAPD2 PKM AGK STIP1 CTNNB1 DNM1 DYNC1H1 ATP5F1B HSP90AB3P | 5.35e-05 | 761 | 150 | 17 | int:AURKB |
| Interaction | RUVBL2 interactions | DYNC2H1 SMC4 PSMC3 ACTG1 CUL7 SRCAP XRCC5 MBIP STIP1 CTNNB1 GNS DYNC1H1 KDM1A DNM2 KPNB1 | 5.79e-05 | 616 | 150 | 15 | int:RUVBL2 |
| Interaction | KIF5B interactions | PSMB7 PSMC3 MCM3 CUL7 XRCC5 ABCE1 DIAPH1 CTNNB1 EXOC7 DYNC1H1 KDM1A | 6.11e-05 | 348 | 150 | 11 | int:KIF5B |
| Interaction | ZNRD2 interactions | 6.12e-05 | 288 | 150 | 10 | int:ZNRD2 | |
| Interaction | PGM5 interactions | 6.38e-05 | 11 | 150 | 3 | int:PGM5 | |
| Interaction | WWOX interactions | GNE ANXA1 FRS3 PSMC3 SSR1 OTUD7B ABCE1 PPM1F DIAPH1 PKM AGK STIP1 KDM1A GNPAT HSP90AB3P | 7.06e-05 | 627 | 150 | 15 | int:WWOX |
| Interaction | RELA interactions | ABCA1 ANXA1 ELP1 TMUB1 PKM PDCD11 ANKRD28 CTNNB1 DYNC1H1 KDM1A MX1 KPNB1 KPNA3 | 7.09e-05 | 485 | 150 | 13 | int:RELA |
| Interaction | SIRT6 interactions | FXR2 TSPYL2 SMC4 ELP1 MCM3 MED1 SRCAP XRCC5 ITPR2 PHF3 NCAPD2 PDS5A CTNNB1 ZBTB11 KDM1A | 7.19e-05 | 628 | 150 | 15 | int:SIRT6 |
| Interaction | CLEC16A interactions | FXR2 DYNC2H1 NLRX1 ELP1 KIF7 MDN1 PMPCA PPM1F NCAPD2 DDX23 ANKRD28 PDS5A EXOC7 DNM2 KPNA3 | 7.32e-05 | 629 | 150 | 15 | int:CLEC16A |
| Interaction | VTA1 interactions | 7.54e-05 | 137 | 150 | 7 | int:VTA1 | |
| Interaction | LMBR1L interactions | HYOU1 DYNC2H1 PSMB7 SMC4 PSMC3 ELP1 SSR1 PGM3 TMUB1 URB1 CEP78 PPM1F NCAPD2 PDS5A CHPF2 CTNNB1 EXOC7 DYNC1H1 KPNB1 | 7.93e-05 | 946 | 150 | 19 | int:LMBR1L |
| Interaction | MEN1 interactions | MYH10 FXR2 ANXA1 SMC4 MED1 CCDC12 SRCAP XRCC5 ITPR2 URB1 MDN1 NCAPD2 AGK PDCD11 DDX23 PDS5A CTNNB1 SPEN ATP5F1B KPNA3 | 7.96e-05 | 1029 | 150 | 20 | int:MEN1 |
| Interaction | MECP2 interactions | MYH10 FXR2 ANXA6 MCM3 SSR1 MED1 SRCAP XRCC5 URB1 TUBGCP3 HELZ2 PKM DNM3 AGK PDCD11 DDX23 PDS5A DNM1 SPEN GNS DYNC1H1 KPNB1 KPNA3 | 8.00e-05 | 1287 | 150 | 23 | int:MECP2 |
| Interaction | CDH9 interactions | 8.46e-05 | 12 | 150 | 3 | int:CDH9 | |
| Interaction | ISG15 interactions | MYH10 ANXA1 PSMB7 PSMC3 ACTG1 XRCC5 HELZ2 PKM DDX23 CTNNB1 DYNC1H1 MX1 ATP5F1B | 8.53e-05 | 494 | 150 | 13 | int:ISG15 |
| Interaction | DCTN1 interactions | HYOU1 ANXA1 SMC4 ACTG1 MCM3 KIF7 NCAPD2 AGK ANKRD28 STIP1 DYNC1H1 KDM1A DNM2 | 9.06e-05 | 497 | 150 | 13 | int:DCTN1 |
| Interaction | MRPS18C interactions | 9.74e-05 | 192 | 150 | 8 | int:MRPS18C | |
| Interaction | LYPD6 interactions | 1.02e-04 | 33 | 150 | 4 | int:LYPD6 | |
| Interaction | BMI1 interactions | FXR2 ACTG1 XRCC5 ITPR2 SLC11A1 PHF3 HELZ2 AGK PDCD11 DDX23 SPEN DYNC1H1 KDM1A ATP5F1B KPNB1 | 1.23e-04 | 659 | 150 | 15 | int:BMI1 |
| Interaction | COMTD1 interactions | 1.29e-04 | 200 | 150 | 8 | int:COMTD1 | |
| Interaction | GPR182 interactions | ABCA2 NLRX1 URB1 MDN1 TUBGCP3 NCAPD2 DNM3 ANKRD28 PDS5A EXOC7 TMUB2 GNPAT | 1.57e-04 | 455 | 150 | 12 | int:GPR182 |
| Interaction | PLK2 interactions | 1.75e-04 | 70 | 150 | 5 | int:PLK2 | |
| Interaction | CDC34 interactions | 1.78e-04 | 328 | 150 | 10 | int:CDC34 | |
| Interaction | MAP1B interactions | PSMB7 SMC4 PSMC3 MCM3 CUL7 ABCE1 DDX23 DNM1 DYNC1H1 ATP5F1B KPNB1 KPNA3 HSP90AB3P | 2.02e-04 | 539 | 150 | 13 | int:MAP1B |
| Interaction | ITGA4 interactions | MYH10 HYOU1 ANXA1 ACTG1 MCM3 XRCC5 ABCE1 PKM STIP1 DYNC1H1 DNM2 ATP5F1B KPNB1 | 2.33e-04 | 547 | 150 | 13 | int:ITGA4 |
| Interaction | RUFY1 interactions | PSMC3 ACTG1 MCM3 XRCC5 PGM3 DIAPH1 PKM DYNC1H1 KDM1A ATP5F1B KPNB1 HSP90AB3P | 2.38e-04 | 476 | 150 | 12 | int:RUFY1 |
| Interaction | THOC2 interactions | 2.40e-04 | 219 | 150 | 8 | int:THOC2 | |
| Interaction | GBE1 interactions | 2.43e-04 | 75 | 150 | 5 | int:GBE1 | |
| Interaction | CD70 interactions | 2.49e-04 | 166 | 150 | 7 | int:CD70 | |
| Interaction | COIL interactions | FXR2 TSPYL2 EPB41L5 XRCC5 URB1 PDCD11 DDX23 PDS5A ZBTB11 KDM1A KIFC1 GNPAT KPNA3 | 2.54e-04 | 552 | 150 | 13 | int:COIL |
| Interaction | LOXL2 interactions | MAGEA4 MYH10 HYOU1 FXR2 ANXA1 NARS1 MCM3 PKM STIP1 ATP5F1B KPNB1 | 2.57e-04 | 410 | 150 | 11 | int:LOXL2 |
| Interaction | TNFSF13B interactions | 2.67e-04 | 119 | 150 | 6 | int:TNFSF13B | |
| Interaction | PSMC3 interactions | MYH10 PSMB7 SMC4 PSMC3 MBIP ITPR2 NCAPD2 DIAPH1 STIP1 CTNNB1 KDM1A | 3.48e-04 | 425 | 150 | 11 | int:PSMC3 |
| Interaction | UBE2M interactions | MYH10 HYOU1 PSMB7 PSMC3 ELP1 MCM3 CUL7 XRCC5 DIAPH1 PKM STIP1 ATP5F1B KPNB1 KPNA3 | 3.69e-04 | 651 | 150 | 14 | int:UBE2M |
| Interaction | ANAPC2 interactions | 3.75e-04 | 234 | 150 | 8 | int:ANAPC2 | |
| Interaction | FLT1 interactions | 3.93e-04 | 179 | 150 | 7 | int:FLT1 | |
| Interaction | AAR2 interactions | HYOU1 ANXA1 PSMC3 ELP1 ACTG1 MCM3 SSR1 CCDC12 PKM DDX23 STIP1 DYNC1H1 ATP5F1B KPNB1 | 4.05e-04 | 657 | 150 | 14 | int:AAR2 |
| Interaction | GAPVD1 interactions | 4.06e-04 | 180 | 150 | 7 | int:GAPVD1 | |
| Interaction | GPR45 interactions | 4.23e-04 | 300 | 150 | 9 | int:GPR45 | |
| Interaction | AR interactions | TRERF1 MYH10 PSMC3 MCM3 MED1 SRCAP XRCC5 MDN1 PHF3 PKM DDX23 PDS5A STIP1 CTNNB1 DYNC1H1 KDM1A KIFC1 ATP5F1B | 4.26e-04 | 992 | 150 | 18 | int:AR |
| Interaction | EFNA4 interactions | 4.31e-04 | 239 | 150 | 8 | int:EFNA4 | |
| Interaction | RNF123 interactions | TBC1D30 FXR2 SMC4 NARS1 ACTG1 XRCC5 ZZEF1 ITPR2 URB1 MDN1 ABCE1 PKM PDS5A STIP1 ZBTB11 DYNC1H1 | 4.35e-04 | 824 | 150 | 16 | int:RNF123 |
| Interaction | CD274 interactions | 4.54e-04 | 369 | 150 | 10 | int:CD274 | |
| Interaction | CYFIP1 interactions | 4.55e-04 | 303 | 150 | 9 | int:CYFIP1 | |
| Interaction | LGALS9 interactions | ABCA2 MYH10 HYOU1 SMC4 URB1 MDN1 CLCN3 NCAPD2 PDCD11 CTNNB1 DYNC1H1 ATP5F1B KPNB1 | 4.63e-04 | 588 | 150 | 13 | int:LGALS9 |
| Interaction | TRIM58 interactions | 4.87e-04 | 21 | 150 | 3 | int:TRIM58 | |
| Interaction | GMPR2 interactions | 4.87e-04 | 21 | 150 | 3 | int:GMPR2 | |
| Interaction | G3BP1 interactions | MAGEA4 MYH10 FXR2 ANXA1 ANXA6 SMC4 PSMC3 DAZL NCAPD2 HELZ2 PDCD11 STIP1 CTNNB1 GNS DYNC1H1 KPNB1 | 5.03e-04 | 835 | 150 | 16 | int:G3BP1 |
| Interaction | APOBEC3C interactions | 5.10e-04 | 187 | 150 | 7 | int:APOBEC3C | |
| Interaction | CTNNB1 interactions | MYH10 AUH EPB41L5 PSMC3 ACTG1 XRCC5 OTUD7B CEP78 ABCE1 PKM STIP1 CTNNB1 CDH10 DYNC1H1 KDM1A CDH15 ATP5F1B KPNB1 | 5.20e-04 | 1009 | 150 | 18 | int:CTNNB1 |
| Interaction | FER interactions | 5.20e-04 | 50 | 150 | 4 | int:FER | |
| Interaction | FRK interactions | 5.20e-04 | 50 | 150 | 4 | int:FRK | |
| Interaction | FOXB1 interactions | 5.25e-04 | 135 | 150 | 6 | int:FOXB1 | |
| Interaction | DCTN5 interactions | 5.37e-04 | 89 | 150 | 5 | int:DCTN5 | |
| Interaction | WDR5 interactions | HYOU1 FXR2 NARS1 PSMC3 ACTG1 PTPN21 XRCC5 MBIP ABCE1 DIAPH1 PKM AGK PDCD11 CTNNB1 UTY DYNC1H1 KDM1A DNM2 ATP5F1B | 5.42e-04 | 1101 | 150 | 19 | int:WDR5 |
| Interaction | TOP3B interactions | ABCA2 MYH10 HYOU1 FXR2 NLRX1 ACTG1 DAZL SRCAP XRCC5 ZZEF1 ITPR2 URB1 NADSYN1 MDN1 SPHK1 NCAPD2 HELZ2 PDCD11 ZFYVE26 LRRC14 HERC1 SPEN DYNC1H1 | 5.48e-04 | 1470 | 150 | 23 | int:TOP3B |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 6.88e-04 | 7 | 105 | 2 | 1201 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 1.46e-03 | 10 | 105 | 2 | 1178 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.98e-03 | 43 | 105 | 3 | 409 | |
| GeneFamily | Dyneins, cytoplasmic | 2.50e-03 | 13 | 105 | 2 | 538 | |
| GeneFamily | Annexins|Endogenous ligands | 2.50e-03 | 13 | 105 | 2 | 404 | |
| GeneFamily | ATP binding cassette subfamily A | 2.90e-03 | 14 | 105 | 2 | 805 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 3.24e-03 | 51 | 105 | 3 | 870 | |
| GeneFamily | Myosin heavy chains | 3.34e-03 | 15 | 105 | 2 | 1098 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.81e-03 | 18 | 105 | 2 | 91 | |
| GeneFamily | Armadillo repeat containing|Importins | 4.81e-03 | 18 | 105 | 2 | 596 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SFMBT1 GNE AUH MED1 ZZEF1 CEMIP MDN1 ATP11B ABCE1 PHF3 SLC20A2 TUBGCP3 ANKRD28 PDS5A DMD ZBTB11 SPEN KPNA3 | 2.10e-06 | 856 | 150 | 18 | M4500 |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP | 2.08e-05 | 200 | 150 | 8 | M5261 | |
| Coexpression | IBRAHIM_NRF1_UP | HYOU1 TBC1D30 FXR2 NARS1 PSMC3 SSR1 ABCE1 PKM CHPF2 STIP1 EXOC7 | 3.19e-05 | 420 | 150 | 11 | M42509 |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | MYH10 SMC4 PSMC3 MCM3 SSR1 XRCC5 INPP4B NADSYN1 ROBO1 STIP1 DHTKD1 KDM1A KIFC1 KPNB1 | 3.21e-05 | 669 | 150 | 14 | M18635 |
| Coexpression | KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP | HYOU1 AUH ANXA6 NARS1 ACTG1 XRCC5 SERPINI1 GYG1 PKM STIP1 DNM1 DYNC1H1 KDM1A GNPAT | 3.83e-05 | 680 | 150 | 14 | M2107 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE | NLRX1 DGKG XPNPEP1 CPNE5 INPP4B GTPBP2 CLCN3 SPHK1 DNM3 MTHFD2L ANKRD28 GMPR HERC1 UTY | 4.77e-05 | 694 | 150 | 14 | M45731 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | ANXA1 SMC4 PSMC3 ELP1 MCM3 XPNPEP1 SSR1 GMPR2 XRCC5 INPP4B ITPR2 ABCE1 TUBGCP3 DDX23 GMPR GNS MMUT DNM2 ATP5F1B KPNB1 KPNA3 | 4.96e-05 | 1399 | 150 | 21 | M535 |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-07 | 187 | 150 | 8 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 192 | 150 | 8 | 796e04365b2ea645e14d8970c8c22ff96ddd75de | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-07 | 192 | 150 | 8 | 0134967d36b5dac1e4646d1a555ca8bb4eeac8ef | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 195 | 150 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 195 | 150 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 181 | 150 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 181 | 150 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-06 | 185 | 150 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 189 | 150 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 189 | 150 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 190 | 150 | 7 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-06 | 190 | 150 | 7 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | a804cb101c3a5585f72217e1143584b1ca436724 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-06 | 193 | 150 | 7 | d0dcc0c11ccf99ff6b07e456d25b9742649aadd8 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.20e-06 | 193 | 150 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-06 | 197 | 150 | 7 | 470e23dee4ca35e1fd021b7cdd58fcbc90639837 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.61e-05 | 158 | 150 | 6 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.79e-05 | 161 | 150 | 6 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 162 | 150 | 6 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 162 | 150 | 6 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 162 | 150 | 6 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.05e-05 | 165 | 150 | 6 | 8003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 167 | 150 | 6 | f90cf0f29c14df4f211193326699e599ef955fa4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV5/7_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-05 | 168 | 150 | 6 | 235c368669c017e13a7312fce3d8b91d7d106c7a | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 171 | 150 | 6 | b3ea26d181f91ea07074f403e7dca9b6b671b1a2 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.59e-05 | 172 | 150 | 6 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-05 | 173 | 150 | 6 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.68e-05 | 173 | 150 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 175 | 150 | 6 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.86e-05 | 175 | 150 | 6 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.95e-05 | 176 | 150 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.95e-05 | 176 | 150 | 6 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-05 | 176 | 150 | 6 | cb8fd56a4f935cdda19d7ab43382cdda7c307667 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.35e-05 | 180 | 150 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.45e-05 | 181 | 150 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 185 | 150 | 6 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-05 | 185 | 150 | 6 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | (5)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.02e-05 | 186 | 150 | 6 | acbca8cc048d87faf859b3e77bdb38d0a3dad71c | |
| ToppCell | (5)_Pericytes-(50)_Pericytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.02e-05 | 186 | 150 | 6 | 67b59defdd1ed3608229cc5e2a3b480d92312afa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.14e-05 | 187 | 150 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 187 | 150 | 6 | accb8a78b885703a27d4b560f0053f03d82ff3af | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.14e-05 | 187 | 150 | 6 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.14e-05 | 187 | 150 | 6 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.27e-05 | 188 | 150 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COPD-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 4.27e-05 | 188 | 150 | 6 | 9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l39|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.27e-05 | 188 | 150 | 6 | a5e7a363fbd5ae4d9312cf6f9941413d6a5c0b4d | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.40e-05 | 189 | 150 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.53e-05 | 190 | 150 | 6 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 4.53e-05 | 190 | 150 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 191 | 150 | 6 | 72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0 | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 191 | 150 | 6 | 6e7f589efc997f32175e0789c5ea7ca46e1389b8 | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.66e-05 | 191 | 150 | 6 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 191 | 150 | 6 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 3ce403e0beedb544edeb3ae6eb30267040d00c21 | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.80e-05 | 192 | 150 | 6 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 192 | 150 | 6 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 192 | 150 | 6 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-05 | 193 | 150 | 6 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-05 | 193 | 150 | 6 | 323d1f3f4fbeb93ba857fc135d8aa0b897f98ac5 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.94e-05 | 193 | 150 | 6 | 9104b572d9c3c99080e4b7455993fbb944bf117d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.08e-05 | 194 | 150 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.08e-05 | 194 | 150 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.23e-05 | 195 | 150 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19_Mild-PLT_5|COVID-19_Mild / Disease Group and Platelet Clusters | 5.23e-05 | 195 | 150 | 6 | bdf9a6ea1bd83c72a834c45f86ce3f4643a9bef3 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.23e-05 | 195 | 150 | 6 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.23e-05 | 195 | 150 | 6 | 8b2e29f3b12fcc474abdf3707de96e4613ead1bc | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-05 | 197 | 150 | 6 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 5.53e-05 | 197 | 150 | 6 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 121 | 150 | 5 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.69e-05 | 198 | 150 | 6 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.69e-05 | 198 | 150 | 6 | 89986c7756541df364df516329d10775ba0e78a4 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.69e-05 | 198 | 150 | 6 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 5.85e-05 | 199 | 150 | 6 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 5.85e-05 | 199 | 150 | 6 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 199 | 150 | 6 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-05 | 199 | 150 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-05 | 199 | 150 | 6 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.02e-05 | 200 | 150 | 6 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.02e-05 | 200 | 150 | 6 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.02e-05 | 200 | 150 | 6 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 6.02e-05 | 200 | 150 | 6 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | distal-1-mesenchymal-Airway_Smooth_Muscle|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.02e-05 | 200 | 150 | 6 | 4d4d227d4df7cab7293bc8005ca1b0441983f39a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.02e-05 | 200 | 150 | 6 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.01e-04 | 137 | 150 | 5 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.05e-04 | 138 | 150 | 5 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.20e-04 | 142 | 150 | 5 | 66135fee18448cc09a78bc6ede05afd63c72ae21 | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.45e-04 | 148 | 150 | 5 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-04 | 149 | 150 | 5 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 150 | 150 | 5 | 1270f33f9d7e46e55adf1a96e8beee858b95589d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 150 | 150 | 5 | 156118ce1d69522624196410cba18b8354cd0bb4 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.64e-04 | 152 | 150 | 5 | 95944864ce7539ff8de028f5700694931338f3ff | |
| ToppCell | COVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters | 1.64e-04 | 152 | 150 | 5 | 90ba4e8a735ec8921038fa072129535f0e3fd9ae | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-04 | 153 | 150 | 5 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| Drug | 2gzl | 5.36e-07 | 46 | 149 | 6 | CID006102719 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | KIAA0586 CUL7 ZZEF1 PHF3 PPM1F SLC20A2 CHPF2 EXOC7 TMUB2 ZNF574 | 6.56e-07 | 195 | 149 | 10 | 1688_DN |
| Drug | nitroquinoline | 2.72e-06 | 5 | 149 | 3 | CID000025551 | |
| Drug | musk tibetene | 2.72e-06 | 5 | 149 | 3 | CID000067350 | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 5.73e-06 | 195 | 149 | 9 | 3721_DN | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA | 6.22e-06 | 197 | 149 | 9 | 984_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.48e-06 | 198 | 149 | 9 | 3869_DN | |
| Drug | musk moskene | 1.50e-05 | 8 | 149 | 3 | CID000067005 | |
| Drug | 2,4-diamino-6-nitrotoluene | 2.24e-05 | 9 | 149 | 3 | CID000096177 | |
| Drug | 3,5-dinitroaniline | 3.19e-05 | 10 | 149 | 3 | CID000012068 | |
| Drug | 4-(hydroxyamino)quinoline 1-oxide | 3.19e-05 | 10 | 149 | 3 | CID000020753 | |
| Drug | Gp3G | 3.28e-05 | 56 | 149 | 5 | CID000444841 | |
| Drug | Azlocillin sodium salt [37091-65-9]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.71e-05 | 190 | 149 | 8 | 3468_UP | |
| Drug | AC1MQZ6I | 3.71e-05 | 190 | 149 | 8 | CID003509873 | |
| Drug | BOMT | 4.25e-05 | 2 | 149 | 2 | CID000159972 | |
| Drug | Ultravate | 4.25e-05 | 2 | 149 | 2 | CID000048175 | |
| Drug | 3-nitrofluoranthen-6-ol | 4.25e-05 | 2 | 149 | 2 | CID000146572 | |
| Drug | 3-nitrofluoranthen-9-ol | 4.25e-05 | 2 | 149 | 2 | CID000146573 | |
| Drug | 3-nitrofluoranthen-8-ol | 4.25e-05 | 2 | 149 | 2 | CID000146567 | |
| Drug | 1,3,6-trinitropyrene | 4.25e-05 | 2 | 149 | 2 | CID000053229 | |
| Drug | 15-aminopentadecanoic acid | 4.25e-05 | 2 | 149 | 2 | CID015420362 | |
| Drug | AC1L25J4 | 4.25e-05 | 2 | 149 | 2 | CID000041328 | |
| Drug | SKF 7690 | 4.25e-05 | 2 | 149 | 2 | CID000019126 | |
| Drug | 2-methylcarbazole | 4.25e-05 | 2 | 149 | 2 | CID000019290 | |
| Drug | m-nitrobenzamidine hydrochloride | 4.25e-05 | 2 | 149 | 2 | CID000165122 | |
| Drug | demegestone | 4.25e-05 | 2 | 149 | 2 | CID000093057 | |
| Drug | 2-nitrobenzofuran | 4.25e-05 | 2 | 149 | 2 | CID000036328 | |
| Drug | 1,3,6,8-tetranitropyrene | 4.25e-05 | 2 | 149 | 2 | CID000034321 | |
| Drug | musk ambrette | 4.36e-05 | 11 | 149 | 3 | CID000006753 | |
| Drug | AC1L22KK | 4.36e-05 | 11 | 149 | 3 | CID000013830 | |
| Drug | 5286656; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 4.46e-05 | 195 | 149 | 8 | 889_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 6777_DN | |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 7429_DN | |
| Drug | Delcorine; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.62e-05 | 196 | 149 | 8 | 3613_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 6776_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; HL60; HT_HG-U133A | 4.79e-05 | 197 | 149 | 8 | 2709_DN | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 2879_DN | |
| Drug | Azathioprine [446-86-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.96e-05 | 198 | 149 | 8 | 5262_DN | |
| Drug | clotrimazole; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 4.96e-05 | 198 | 149 | 8 | 905_DN | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 5.14e-05 | 199 | 149 | 8 | 2399_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 5.14e-05 | 199 | 149 | 8 | 7000_DN | |
| Drug | magnesium | TRPM6 ZNF143 MYO1A PSMB7 NARS1 ACTG1 DGKB DGKG GRIN2A ITGAM INPP4B NADSYN1 SLC11A1 ABCE1 SPHK1 PKM AGK GRIN3A DNM1 DYNC1H1 ATP5F1B KPNB1 | 5.22e-05 | 1325 | 149 | 22 | CID000000888 |
| Drug | Go7874 | 5.79e-05 | 12 | 149 | 3 | CID005327863 | |
| Drug | AC1OAGGW | 5.92e-05 | 203 | 149 | 8 | CID006857364 | |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.34e-05 | 158 | 149 | 7 | 4136_UP | |
| Drug | musk ketone | 9.48e-05 | 14 | 149 | 3 | CID000006669 | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.09e-04 | 165 | 149 | 7 | 979_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.14e-04 | 166 | 149 | 7 | 1066_UP | |
| Drug | AC1L9HHR | 1.17e-04 | 354 | 149 | 10 | CID000445141 | |
| Drug | AC1L4Q08 | 1.18e-04 | 15 | 149 | 3 | CID000161747 | |
| Drug | sesaminol | 1.18e-04 | 15 | 149 | 3 | CID000094672 | |
| Drug | Vexol | 1.27e-04 | 3 | 149 | 2 | CID000039507 | |
| Drug | Felbamate | 1.27e-04 | 3 | 149 | 2 | DB00949 | |
| Drug | ammonia | NARS1 ACTG1 GRIN2A GMPR2 ITGAM SIRPG NADSYN1 PKM GMPR TGM7 DHTKD1 KDM1A | 1.36e-04 | 509 | 149 | 12 | CID000000222 |
| Drug | AC1L9JUM | 1.44e-04 | 16 | 149 | 3 | CID000446587 | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 174 | 149 | 7 | 864_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.52e-04 | 174 | 149 | 7 | 1044_UP | |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; MCF7; HT_HG-U133A | 1.58e-04 | 175 | 149 | 7 | 3267_UP | |
| Drug | musk xylene | 1.75e-04 | 17 | 149 | 3 | CID000062329 | |
| Drug | laurina | 1.75e-04 | 17 | 149 | 3 | CID000062957 | |
| Drug | silanol | 1.75e-04 | 17 | 149 | 3 | CID000142154 | |
| Drug | Ivermectin [70288-86-7]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.75e-04 | 178 | 149 | 7 | 2213_UP | |
| Drug | AC1L1IZ2 | 1.83e-04 | 304 | 149 | 9 | CID000004795 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.88e-04 | 180 | 149 | 7 | 947_UP | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.08e-04 | 183 | 149 | 7 | 1475_UP | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 2.29e-04 | 186 | 149 | 7 | 1228_UP | |
| Drug | TEOS | 2.46e-04 | 19 | 149 | 3 | CID000006517 | |
| Drug | 5-nitroimidazole | 2.46e-04 | 19 | 149 | 3 | CID000018208 | |
| Drug | library 2 | 2.46e-04 | 19 | 149 | 3 | CID005270634 | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.53e-04 | 189 | 149 | 7 | 836_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 2.53e-04 | 189 | 149 | 7 | 1171_DN | |
| Drug | Cyclosporin A [59865-13-3]; Up 200; 3.4uM; HL60; HT_HG-U133A | 2.53e-04 | 189 | 149 | 7 | 1331_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.53e-04 | 189 | 149 | 7 | 1225_UP | |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HG-U133A | 2.53e-04 | 189 | 149 | 7 | 611_UP | |
| Drug | AC1NDR5F | 2.53e-04 | 4 | 149 | 2 | CID004630253 | |
| Drug | nitromethanamine | 2.53e-04 | 4 | 149 | 2 | CID000061148 | |
| Drug | pyrromycin | 2.53e-04 | 4 | 149 | 2 | CID000196990 | |
| Drug | 1-amino-8-nitropyrene | 2.53e-04 | 4 | 149 | 2 | CID000108113 | |
| Drug | methyl p-nitrobenzoate | 2.53e-04 | 4 | 149 | 2 | CID000012083 | |
| Drug | Ortho Evra | 2.53e-04 | 4 | 149 | 2 | ctd:C511292 | |
| Drug | NSC-107680 | 2.53e-04 | 4 | 149 | 2 | CID000003376 | |
| Drug | anilino acetate | 2.53e-04 | 4 | 149 | 2 | CID000153367 | |
| Drug | c0458 | 2.53e-04 | 4 | 149 | 2 | CID009543178 | |
| Drug | Deladroxone | 2.53e-04 | 4 | 149 | 2 | CID000032327 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.61e-04 | 190 | 149 | 7 | 2629_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.70e-04 | 191 | 149 | 7 | 3890_DN | |
| Drug | ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA | 2.87e-04 | 193 | 149 | 7 | 866_DN | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; HL60; HG-U133A | 2.87e-04 | 193 | 149 | 7 | 1547_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 4241_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 193 | 149 | 7 | 3841_DN | |
| Drug | Conessine [546-06-5]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 2792_DN | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 3071_UP | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 6763_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 6921_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A | 2.96e-04 | 194 | 149 | 7 | 1759_UP | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A | 2.96e-04 | 194 | 149 | 7 | 2711_DN | |
| Drug | AC1Q6S1T | 2.97e-04 | 49 | 149 | 4 | CID000000644 | |
| Drug | AC1L3174 | 2.97e-04 | 49 | 149 | 4 | CID000132558 | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HG-U133A | 3.06e-04 | 195 | 149 | 7 | 1883_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 3.06e-04 | 195 | 149 | 7 | 6918_UP | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 3.03e-09 | 5 | 148 | 4 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 3.03e-09 | 5 | 148 | 4 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 3.03e-09 | 5 | 148 | 4 | DOID:0110197 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.19e-07 | 13 | 148 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TRERF1 MAGEA4 DYNC2H1 NOA1 EFCAB13 ELP1 DGKG HELQ INPP4B SLC6A3 ALKBH8 SNX32 PPM1F ROBO1 ZFYVE26 CTNNB1 DMD SPEN CDH10 | 1.95e-06 | 1074 | 148 | 19 | C0006142 |
| Disease | Neoplasm Invasiveness | 4.40e-06 | 184 | 148 | 8 | C0027626 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 5.24e-06 | 50 | 148 | 5 | C1449563 | |
| Disease | Alcoholic Intoxication, Chronic | 8.98e-06 | 268 | 148 | 9 | C0001973 | |
| Disease | collagen disease (implicated_via_orthology) | 2.63e-05 | 12 | 148 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | Short Rib-Polydactyly Syndrome | 3.41e-05 | 13 | 148 | 3 | C0036996 | |
| Disease | Saldino-Noonan Syndrome | 4.32e-05 | 14 | 148 | 3 | C0036069 | |
| Disease | Majewski Syndrome | 4.32e-05 | 14 | 148 | 3 | C0024507 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 6.44e-05 | 43 | 148 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | Intellectual Disability | PGM3 KIF7 SLC6A3 SHROOM4 GTPBP2 ALKBH8 DIAPH1 ZBTB11 DYNC1H1 CNDP1 | 9.14e-05 | 447 | 148 | 10 | C3714756 |
| Disease | Cardiomyopathy, Dilated | 9.96e-05 | 48 | 148 | 4 | C0007193 | |
| Disease | preeclampsia, fetal genotype effect measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0000668, EFO_0007959 | |
| Disease | MEDULLOBLASTOMA | 3.70e-04 | 6 | 148 | 2 | 155255 | |
| Disease | diamine acetyltransferase 2 measurement | 3.70e-04 | 6 | 148 | 2 | EFO_0802465 | |
| Disease | Medulloblastoma | 3.70e-04 | 6 | 148 | 2 | cv:C0025149 | |
| Disease | sexual dimorphism measurement | ABCA1 EFCAB13 SHBG FRS3 GRIN2A LRRC43 ZZEF1 G6PC3 PMPCA SNX32 ABCE1 DNM3 CTNNB1 HERC1 KPNA3 | 4.64e-04 | 1106 | 148 | 15 | EFO_0021796 |
| Disease | obesity (implicated_via_orthology) | 7.79e-04 | 215 | 148 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | Developmental delay (disorder) | 8.48e-04 | 37 | 148 | 3 | C0424605 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 8.79e-04 | 9 | 148 | 2 | C1846707 | |
| Disease | Glioma | 8.79e-04 | 9 | 148 | 2 | cv:C0017638 | |
| Disease | Muscle Weakness | 1.10e-03 | 10 | 148 | 2 | C0151786 | |
| Disease | medulloblastoma (is_implicated_in) | 1.10e-03 | 10 | 148 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.10e-03 | 10 | 148 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | N6-acetyllysine measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0800036 | |
| Disease | Erectile dysfunction | 1.10e-03 | 10 | 148 | 2 | C0242350 | |
| Disease | Immature Reticulocyte Fraction Measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0009253 | |
| Disease | obsolete_red blood cell distribution width | MYO1A FXR2 SHBG PSMB7 INPP4B ATP11B PMPCA SPHK1 HELZ2 PDS5A GMPR LRRC14 HERC1 CDH15 DNM2 KPNB1 | 1.23e-03 | 1347 | 148 | 16 | EFO_0005192 |
| Disease | Jeune thoracic dystrophy | 1.33e-03 | 11 | 148 | 2 | C0265275 | |
| Disease | Familial dilated cardiomyopathy | 1.41e-03 | 44 | 148 | 3 | C0340427 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 1.50e-03 | 45 | 148 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | body weight | SFMBT1 ZNF143 PAK5 PSMC3 DGKG E4F1 CPNE5 ZZEF1 OTUD7B PHF3 GYG1 DNM3 PLCL1 DMD KPNB1 | 1.73e-03 | 1261 | 148 | 15 | EFO_0004338 |
| Disease | myopathy (implicated_via_orthology) | 1.81e-03 | 48 | 148 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | high grade glioma (biomarker_via_orthology) | 2.51e-03 | 15 | 148 | 2 | DOID:3070 (biomarker_via_orthology) | |
| Disease | atrial fibrillation | 2.76e-03 | 371 | 148 | 7 | EFO_0000275 | |
| Disease | Polydactyly | 2.91e-03 | 117 | 148 | 4 | C0152427 | |
| Disease | Multiple congenital anomalies | 3.23e-03 | 17 | 148 | 2 | C0000772 | |
| Disease | Depressive disorder | 3.46e-03 | 289 | 148 | 6 | C0011581 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.90e-03 | 206 | 148 | 5 | C0152013 | |
| Disease | acute lymphoblastic leukemia, response to antineoplastic agent | 4.04e-03 | 19 | 148 | 2 | EFO_0000220, GO_0097327 | |
| Disease | squamous cell carcinoma (is_marker_for) | 4.04e-03 | 19 | 148 | 2 | DOID:1749 (is_marker_for) | |
| Disease | age at menopause | 4.29e-03 | 302 | 148 | 6 | EFO_0004704 | |
| Disease | serum alanine aminotransferase measurement | HYOU1 EFCAB13 NARS1 ACTG1 SSR1 LRRC43 SERPINA6 OTUD7B DIAPH1 MX1 ATP5F1B | 4.50e-03 | 869 | 148 | 11 | EFO_0004735 |
| Disease | Global developmental delay | 4.59e-03 | 133 | 148 | 4 | C0557874 | |
| Disease | platelet component distribution width | FLT4 ZZEF1 INPP4B SIRPG DNM3 ANKRD28 PDS5A HERC1 DNM1 ATP5F1B | 4.90e-03 | 755 | 148 | 10 | EFO_0007984 |
| Disease | testosterone measurement | TRPM6 DCHS2 FXR2 SHBG ACTG1 DGKB PTPN21 CCDC12 SRCAP SHROOM4 URB1 SLC20A2 DNM3 KPNB1 | 5.00e-03 | 1275 | 148 | 14 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGDAISDMLVIEAIL | 416 | O95394 | |
| ELMENTDVIIVAGGD | 111 | Q53H12 | |
| EDEIVSLSLGSEIVM | 246 | Q96BT7 | |
| MEEEIAALVIDNGSG | 1 | P63261 | |
| VEDNGLLVGLAEEEM | 106 | Q9BX10 | |
| VEGEMLVLVCSVAEG | 301 | Q96PJ5 | |
| MDEADVLGDRIAIIS | 1091 | O95477 | |
| EGAAEMLIDTLGASI | 801 | O15084 | |
| TNMILDDEGVLGSIE | 511 | Q5JTW2 | |
| LAQTLTDGGVMDELI | 1326 | P11532 | |
| TDGGVMDELINEELE | 1331 | P11532 | |
| AEGDETGVMDSLLEA | 1191 | O60610 | |
| LIAGGLMTQEEVSEI | 466 | Q96HY7 | |
| EIDGVDMRAEVGLLS | 481 | Q8WUJ3 | |
| DIIAILGMDELSEED | 436 | P06576 | |
| MKGLGTDEDTIIDII | 376 | P08133 | |
| MEGDGVTQELLDSIL | 196 | Q29RF7 | |
| VLGADTRATEGMVVA | 56 | Q99436 | |
| VMTELINGGEDVLIF | 1331 | Q14571 | |
| AMKGLGTDEDTLIEI | 126 | P04083 | |
| VVMEFLEGGALTDIV | 521 | Q9P286 | |
| VVVADTMLRDSGGEA | 311 | Q6GQQ9 | |
| VEGVRMEEIVEGCTG | 561 | P35222 | |
| MAGDEASTIAEIIEE | 441 | O00505 | |
| MDTTELLGGFEQVDL | 2096 | Q9NU22 | |
| VLGTIAMEGDSASEE | 206 | P43358 | |
| GDLVVAIDGVNTDTM | 46 | O75112 | |
| EEFTVREDLMGLAIG | 231 | P51116 | |
| EIGEMVGLNSEEVER | 301 | Q9UBC5 | |
| GMEVDLVTGLAIEEA | 296 | Q13825 | |
| IGVITKLDLMDEGTD | 201 | Q05193 | |
| MIKLGLGTDEDEVAA | 556 | Q58FF7 | |
| MLAVEVSEAEGGIRE | 1 | A6NMX2 | |
| VSVVKMGEIEDGEAD | 181 | O15327 | |
| IDRGTEVDIASGMAI | 246 | Q86YB7 | |
| MESTLGAGIVIAEAL | 1 | Q9BUM1 | |
| DGSLGLIEVVDVSTM | 3556 | Q15751 | |
| GSGQDEVFEEIAMLV | 381 | Q9BW19 | |
| IGVITKLDLMDEGTD | 201 | Q9UQ16 | |
| EREEMAVTEQLAAGG | 286 | P98095 | |
| AGEVGALDKSVLEEM | 96 | Q14999 | |
| VEGLDEVLSLLEMGN | 186 | Q2M1P5 | |
| DEILEASDGIMVARG | 281 | P14618 | |
| IELAIVGSDMQEVIG | 141 | P49279 | |
| EGDTGGTMEITEAAL | 236 | Q96CW5 | |
| ELAMIGEEECVLGLT | 611 | O95163 | |
| AGNVVTGEMVEELIL | 156 | Q9P2T1 | |
| TGEMVEELILSGADI | 161 | Q9P2T1 | |
| ILDGNEIEEISGLEM | 221 | Q96M69 | |
| DDVLDQMGASILGVE | 591 | Q86UT6 | |
| TDVAGRGIDIQDVSM | 721 | Q9BUQ8 | |
| IGVITKLDLMDEGTD | 201 | P50570 | |
| DALDGLMLEGENIVS | 401 | Q9UPT5 | |
| LSLEVVMAIEAGLGD | 146 | Q8TCU5 | |
| AIIAMVTAEEEGGRE | 991 | Q16825 | |
| TTTGLLVIHMEGEDV | 2121 | Q6V1P9 | |
| MAGTVVLDDVELREA | 1 | P25205 | |
| SDQLLEVVGLEGAME | 701 | P49619 | |
| VGEAGDESIFSIMID | 816 | Q8NCM8 | |
| ELAIVAGEFTDSEIM | 361 | P61221 | |
| EATIGDVIGASDTME | 461 | Q9HCM4 | |
| EMSLDEIEQVILVGG | 371 | Q9Y4L1 | |
| DEVIMVDVLDSGDSA | 56 | P46976 | |
| AAGIMENISDDVIVG | 711 | O60341 | |
| VRGEDEAAMVESVGL | 76 | Q9Y223 | |
| KVDSGDSEVVDGLML | 456 | O15228 | |
| DIEVGTIIGTVMARD | 396 | Q9Y6N8 | |
| VDDEGVELGSGVMEL | 26 | O43559 | |
| SDQLLEVVGLEGAME | 711 | Q9Y6T7 | |
| DIVTRGLVAMAVEGV | 1986 | Q9BZC7 | |
| EVVLAADLLEGDMIA | 676 | Q8IY85 | |
| EDALMAVSTLVEVLG | 626 | Q14974 | |
| LLLTDDQDEVLGGMT | 51 | P15586 | |
| ENTTAVEEIGRTEMG | 96 | Q9NS73 | |
| SVVLGISSREGEEVM | 1671 | Q14204 | |
| TVFVGGIDVRMDETE | 41 | Q92904 | |
| VIVAAEAELGDGEMA | 146 | Q66K89 | |
| MEATTAGVGRLEEEA | 1 | Q8WUD4 | |
| SLGLVVVDELHMIGE | 456 | Q8TDG4 | |
| AGNVVTGEMVEELIL | 156 | P36959 | |
| TGEMVEELILSGADI | 161 | P36959 | |
| MVTVGEDGLLDTVAR | 1086 | Q9BYK8 | |
| EAEEGGVEMKLASEL | 446 | Q08357 | |
| FMEAIEAVSGVDVGR | 266 | P55291 | |
| IEGSLLVMAVGEAAL | 286 | Q96RY7 | |
| SSEMVFELEGVELGA | 221 | Q9BTV7 | |
| DLGDVLEEMGIADLF | 311 | P08185 | |
| DVDRIVGLDQVTGMT | 621 | P35580 | |
| EDIMLKEGLGASEAV | 606 | Q8NC60 | |
| IIVGVGQAEFDAMVE | 486 | Q9HCH3 | |
| IGEEDDDLMDVALIG | 1566 | Q15648 | |
| EGEMNESAGVLAEIV | 351 | Q8N309 | |
| QEEVEGELAELAMGF | 51 | P49593 | |
| EEGSEAAAVSGMIAI | 346 | Q99574 | |
| EFILMGGTVDTVELE | 411 | Q10713 | |
| VSLTVEEREALGGMD | 36 | O14607 | |
| VLSAVEDRMDELGAG | 231 | Q96LD4 | |
| VIEREDGLDGETIFM | 196 | P43307 | |
| VLLGVDLGSMDEEEE | 181 | P31948 | |
| EIVGGSMRIFDSEEI | 471 | O43776 | |
| MEGDSVLLEVDGEEV | 136 | P04278 | |
| MAEIGLGEEEVDHEL | 1296 | Q9ULL8 | |
| TEIVDDIAGMISQLG | 506 | O15457 | |
| QDLTMDGLVDLTVGA | 591 | P11215 | |
| SGGSMVVAVIQDDLD | 3081 | Q6ZRS2 | |
| EESIEMFGDINLTLG | 6 | Q7Z745 | |
| RLEEAGGATSVQIEM | 1151 | P13533 | |
| LGLTEVAGEEELQMI | 21 | Q9P1W8 | |
| LDMVDVLVEGSEGLD | 751 | O60287 | |
| VEEMLASEVLGDFLG | 171 | O43556 | |
| MVGGEAAAAVEELVS | 1 | Q96HQ2 | |
| TMEEELGLVGATADD | 976 | Q15021 | |
| AGQEEEEALEGLEVM | 691 | Q9P2E5 | |
| EGMEEAGSVALEELV | 196 | Q96KN2 | |
| EELLDGAGVIMDFQT | 26 | P51790 | |
| IGIVFIGNSEETMEV | 541 | Q9Y2G3 | |
| GMFLDLVVQEVLEDG | 846 | Q14690 | |
| ADVDGNGIMLEDTSV | 251 | Q15111 | |
| VVVTGETMEALEAVA | 986 | O95625 | |
| AMVTAEGTEGEQVAI | 551 | P52747 | |
| AIIGLETIMLFIDGD | 226 | Q9NQW7 | |
| ETEAAQVLADMRGVG | 51 | Q9H2G4 | |
| VICAEVLGSMEIAGE | 1256 | Q9BX84 | |
| EGMETDEAVSGILET | 2261 | Q96T58 | |
| IVEMGDVGAREAVLS | 96 | Q9H6E5 | |
| QDGIGEEVLKMSTEE | 26 | P17980 | |
| LAEAEAAVGLAVMET | 856 | Q6ZN55 | |
| AAVGLAVMETAVEAL | 861 | Q6ZN55 | |
| GMESVITGLIDEFQL | 426 | Q01959 | |
| EGSEDKGSMEIVILV | 766 | P35916 | |
| TVVGLDDIMDEGVVK | 81 | Q92576 | |
| GRMGSSLVIEISEEE | 761 | Q9NTJ3 | |
| QMLTLGGDAELELVD | 1151 | Q9NTJ3 | |
| MELSDVTLIEGVGNE | 21 | Q71RG4 | |
| ALILEVMEGNEGDAL | 346 | Q9Y2I9 | |
| VGTNMVGERESEVAE | 241 | Q9Y6N7 | |
| AEELDVMYGGVLVQE | 456 | O15195 | |
| SDMVKEGAAVIDVGI | 276 | Q9H903 | |
| EGDGTVDAENMLEAL | 126 | O43149 | |
| MEGLLSVALQGAELE | 1 | Q9Y2P0 | |
| QLDADAGSGMEEVEL | 6 | Q9UHJ3 | |
| GVFAVDGELMVSEAV | 336 | Q9NYA1 | |
| MTLIEGVGDEVTVLF | 1 | Q9BVT8 | |
| GIAEVEETGRSMLVL | 586 | Q96PF1 | |
| EALITGMSGLKEVDD | 191 | Q86XE0 | |
| VGQEIGFTMDEVDSL | 1706 | Q68DK2 | |
| VMISLEGEDGLDEIY | 211 | P13010 | |
| EALAETIAVMLGDRE | 996 | Q9BVV6 | |
| GGVMEEAEVVDTDLL | 1171 | Q96PN7 | |
| VLDMTGLLDDGVEQD | 116 | Q15048 | |
| ITALMQGEETVGEED | 386 | P20591 | |
| IDMGLDGVEIITNAS | 186 | Q6IA69 | |
| DVGMAGVAIDTVEDT | 156 | P22033 | |
| VAESEEKVVGMVGAL | 111 | Q9UHE5 | |
| DLALLQFVGDGEMEE | 776 | Q12879 |